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Abstract 
 
Objective: To evaluate a specialist weight management treatment service for patients 
with severe obesity and follow up at 3 months, monitoring changes in weight, BMI 
and clinical outcome variables. Changes in food intake, self esteem and health related 
quality of life (HRQL) were also compared to pre- and post- intervention.   
Design: Step by step is a new obesity service which specifically targets obese patients 
at greater risk of further ill health. Only patients who are referred by their G.P or 
health professional have been included in the evaluation. After an assessment 
appointment all patients chose one of two treatment options: group programme, 
individual dietetic care or both. The group programme offered weekly contact over 
twelve weeks and monthly follow up thereafter in a community setting. One-to-one 
care offered monthly appointments with the Dietitian over a three month period.  
Subjects: A total of 50 patients with a BMI>30kg/m
2 
, mean age 59 years, mean 
weight for males 113.5kg, BMI 39,3kg/m
2
 and females 92.7kg, BMI 36.5kg/m
2
. 
Main outcome measures: Weight, BMI, Total cholesterol, LDL, TG, HDL, FBG, 
HbA1C, Blood Pressure, Food Intake, Self esteem and quality of life were measured 
pre and post intervention 
Results: Patients who attended the group programme showed a significant weight 
loss 1.99kg (P<0.05) and BMI 0.66kg/m
2 
at three months. Male patients lost more 
weight (3.9kg) during the three month period compared to females (1.4kg). Data was 
not available for individual dietetic care. Patients significantly reduced intake of 
negative marker foods (P<0.00). No changes were observed between self esteem pre 
 4 
and post programme however quality of life score increased considerably, 44.83 (S.D. 
34.26) to 70.37 (S.D.15.86) P<0.001.  
Conclusion: patients attending a 12 week weight management programme run by 
community dietitians and foodworkers achieve clinically worth while reductions in 
weight and BMI, improvements in food choice and choice and improved HRQL 
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Chapter 1 
1.0 Introduction  
Obesity is a not a new a phenomenon  however the recent increase in the prevalence 
of overweight and obesity in virtually every country in the industrialised world is 
alarming (Haslam, 2007). The latest projections from the WHO (2006) estimates that 
approximately 1.2 billion people in the world are overweight, of which at least 300 
million are obese. In some countries, including the USA and the UK, the rates of 
obesity have more than doubled in the last 25 years, and being overweight has 
become the norm for adults (Foresight, 2007). 
 
1.1 Classification of obesity  
The National Institute for Clinical Excellence (NICE, 2006) report classifies obesity 
using the body mass index.  
This is defined as: 
BMI = weight (Kg) 
          Height
2
 (m) 
The NICE classification of obesity is shown in table 1.1a. Though BMI should be 
used as a measure of overweight in adults, the use of this in the general population 
needs to be interpreted with caution because it is not a direct measure of adiposity, 
thus individuals with a particularly well developed musculature may be classified as 
obese. Some other population groups such as Asians and older people have 
comorbidity risk factors that would be of concern at different BMI cut off points 
which are lower for Asian adults and higher for older people (NICE, 2006).  
 14 
 
 
 
 
 
 
 
 
Waist circumference may also be used, in addition to BMI, in people with a BMI less  
than 35 kg/m
2
  (NICE, 2006).   
 
 
Table 1.1a. The degree of overweight or obesity in 
adults should be defined as follows 
Classification                       BMI (kg/m
2
)  
Healthy weight                            18.5–24.9  
Overweight                                    25–29.9  
Obesity I                                       30–34.9  
Obesity II                                     35–39.9  
Obesity III                                   40 or more  
NICE (2006) 
Table 1.1b: BMI and waist circumference 
BMI classification                                                                     Waist circumference  
                                                                               Low                                  High                                  Very high  
Overweight                                               No increased risk                 Increased risk                            High risk  
Obesity I                                                   Increased risk                         High risk                          Very high risk  
For men, waist circumference of less than 94 cm is low, 94–102 cm is high and more than102 cm is very high.  
For women, waist circumference of less than 80 cm is low, 80–88 cm is high and more than 88 cm 
NICE (2006)  
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1.2 Aetiology of Obesity  
At first the cause of obesity seems simple. Over a period of time, energy intake 
exceeds energy expenditure. But this simplistic view, which is widely held to be true, 
hides the intricacies inherent in how we acquire and use energy. In fact, the causes of 
obesity are complex and multifaceted (Foresight, 2007). This variability is an 
important feature in that it points to a range of different solutions. Indeed, the 
multifactorial condition of obesity is inherently unsuited to a „one size fits all‟ 
approach. The concept of a family of „obesities‟ is a useful way of recognising this 
complexity (Foresight, 2007) 
 The existing evidence collated from research in medicine, the life sciences, the social 
sciences and economics tells us a great deal about these different causes. 
However most of the evidence is generally not well integrated across the different 
disciplines. Consequently, there is a continuing debate about the relative importance 
of each cause or variable. In addition, the interactions between different variables are 
poorly understood.   
The examples from a biological perspective include the role of food as a fundamental 
biological necessity. The hunger drive is very powerful and compels humans to search 
out food. By contrast, there is limited sensitivity to abundance. The feelings of having 
had enough (satiety cues) are weak and easily overridden by external factors such as 
the sight of food or how it tastes (Bloom, 2007). A practical example is the contrast 
between the difficulties of skipping a meal or not eating before the next mealtime, 
compared to the ease of succumbing to a dessert or cheese board; even though we 
may already feel full after eating a main course. Other research studies focus on 
specific aspects of the „systems map‟ (Foresight, 2007) and go far beyond the remit of 
this evaluation. 
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1.3 Prevalence and future trends of obesity in the UK 
A series of annual health surveys collect information on various aspects of the 
nation‟s health throughout the UK. The health survey for England including Wales, 
records BMI and other measurements such as waist and hip size,  making it possible 
to monitor the increasing prevalence of obesity in the population and its distribution 
across age groups, gender, socio-economic status and region (DOH, 2007). 
  Though BMI needs careful interpretation on an individual basis, it provides a 
meaningful picture at the population level. The population median (BMI) has 
progressively increased among adults during the past three decades leading to almost 
two-thirds of adults and a third of children who are either overweight or obese 
(Foresight, 2007). It has been suggested that, without clear action, these figures will 
rise to almost nine in ten adults and two-thirds of children by year 2050 (Foresight, 
2007).  Today the prevalence of obesity in the UK is greater than in other parts of 
northern and western Europe (with the exception of Germany). Data published in the 
Health survey for England (2004) demonstrated nearly a quarter of men (23.6%) and 
women (23.8%) were obese in England, and Wales which was predicted to increase to 
approximately 33% in men and 28% in women by 2010. Prevalence of obesity among 
men in 2004 shows a marked gradient in relation to social class with the highest 
prevalence in social class V (28%) compared to (18%) in social class II, for women 
the social class disparity has been longstanding while for men it has only become 
pronounced in recent years. In 2007, Lobstein, Jackson and Leach found the factors 
underpinning this are poorly understood. Comparisons of populations internationally 
show that, above a basic threshold, both obesity and diabetes are linked less strongly 
to absolute levels of national wealth than they are to indicators of inequalities within 
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nations which suggests obesity is associated with the degree of relative social 
inequality. 
 
1.4  Incidence of obesity 
The incidence of overweight and obesity in the UK varies with age and with the 
highest proportion of men and women being overweight or obese aged 55-64 years. 
The risk of obesity is also greater within Caucasian and Bangladeshi Populations 
(26% of Caucasian men, 23% of Caucasian women and 24% of Bangladeshi women 
(DOH, 2007). Other measures that give an estimate of central or abdominal fatness, 
such as waist circumference and waist to-hip ratio also show this rising trend. These 
measures may be more accurate predictors of disease (Foresight, 2007).  
1.5 Health risks of obesity  
Obesity is an independent risk factor for premature death, but is also strongly 
associated with a number of other serious medical conditions. One of the challenges 
for policy makers, public health practitioners and other stakeholders is that the public 
and the media often focus on excess weight as an appearance issue, rather than one 
that concerns health. Still, obesity is known to lead to both chronic and severe medical 
problems, long documented through WHO reports (DOH, 2007).  Not only do these 
medical conditions adversely affect people‟s quality of life, but they create serious, 
rising financial and social burdens. Several conditions are associated with overweight 
and obesity. They include type 2 diabetes, hypertension, coronary heart disease and 
stroke, metabolic syndrome, osteoarthritis and cancer (Kopelman, 2007).    
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1.6 Future disease attributable to overweight and obesity 
 
A sense of urgency has extended beyond the healthcare sector to Government to try 
and understand the causes of obesity and to consider how it can be addressed. A 
critical step in managing what some see as an epidemic is to gain insight into the 
likely prevalence of overweight and obesity in the future. Mcpherson, Marsh, & 
Brown, 2007 assessed the impact of overweight and obesity on the incidence of 
disease in the future by using a microsimulation that imposed the known association 
between BMI and health risks from the present day on simulated populations to 2050. 
Predicted increases in disease incidence arise solely as a result of changes in 
population BMI. The analysis indicated the greatest increase in the incidence of 
disease would be for type 2 diabetes (alarmingly 70% increase by 2050) with 
increases of 30% for stroke and 20% for coronary heart disease over the same period 
(Mcpherson et al. 2007).  
 
1.7 Economic costs of overweight and obesity 
 
The costs of obesity are very likely to grow significantly in the next few decades. 
Apart from the personal and social costs such as morbidity, mortality, discrimination 
and social exclusion, there are significant health and social care costs associated with 
the treatment of obesity and its consequences, as well as costs to the wider economy 
arising from chronic ill health. The House of Commons Health Select Committee 
estimated that the total annual cost of obesity and overweight for England in 2002 was 
nearly £7 billion. This total includes direct costs of treatment, the cost of dependence 
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on state benefits, and indirect costs such as loss of earnings and reduced productivity 
(Commons, 2004). 
The Committee estimated that the direct healthcare costs for the treatment of obesity 
alone and its consequences were between £991 million and £1,124million in 2002, 
equating to 2.3–2.6% of NHS expenditure (2001/2002). Other indirect costs include 
higher levels of sickness and absence from work, decreased household incomes, 
earlier retirement and higher dependence on state benefits which arise from being 
obese (Commons, 2004).  
 
1.8 Obesity in Liverpool  
A report devised by the (DOH, 2009) indicated the health of people in Liverpool is 
generally worse than the average for England and the city has seen a significant rise in 
obesity in recent years:  
  An estimated 40% of the Liverpool adult population are overweight and 20% 
obese.  
 In Liverpool estimates predict obesity results in over 130,000 sick days every 
year  
 The NHS in Liverpool spends £5 million a year on treating obesity related 
problems, which cost the city‟s wider economy an additional £15m a year.  
If current trends continue, up to half of all children and one third of adults in 
Liverpool will be overweight or obese by 2020. In April 2008 Liverpool PCT 
launched its healthy weight: Healthy weight: Healthy Liverpool Strategy with the 
objective of reducing the level of obesity in the city from 2010. The community 
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health department already runs a number of programmes including the Community 
Food Worker programme and active city which aim to motivate people to focus on a 
healthier lifestyle. Liverpool community dietetic department and community food 
workers have also supported campaigns which have taken place throughout the city 
including the Liverpool Challenge, devised and managed by the trusts social 
marketing team which aimed to galvanise the city into thinking about healthy 
lifestyles in relation to their weight and encouraging large numbers of the population 
to make healthy changes as part of a city wide initiative (LPCT, 2009).  
1.9 Benefits of weight loss 
The benefits of weight loss in overweight and obese individuals include 
improvements in most parameters: physical, metabolic, endocrinological and 
psychological complications. The research of Mulvihill and Quigley (2003) indicated 
intentional weight loss may also reduce obesity-related mortality. The Scottish 
Intercollegiate Guidelines Network (SIGN, 1996) describes in more detail below the 
many benefits that can derive from a modest weight loss.   
Table 1.9a. The benefits associated with a 5-10% weight loss 
Mortality                                                                                Over 20% fall in total mortality 
                                                                                                Over 30% fall in diabetes-related  deaths 
                                                                                                Over 40% fall in obesity-related  cancer deaths 
Blood pressure (in hypertensive people)                             Fall of 10 mmHg systolic 
                                                                                                 Fall of 20 mmHg diastolic 
Diabetes (in newly diagnosed people)                                 Fall of 50% in fasting glucose 
Lipids                                                                                     Fall of 10% total cholesterol 
                                                                                                Fall of 15% low density lipoprotein 
                                                                                                Fall of 30% triglycerides 
                                                                                                Increase of 8% high density lipoproteins 
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Other benefits                                                                   Improved lung function, and reduced 
                                                                                            back and joint pain, breathlessness, and frequency of sleep                           
apnoea Improved insulin sensitivity and ovarian function when more than 5% weight loss occurs  
(SIGN, 1996) 
 
The health and economic consequences described so far make it clear that obesity is a 
problem that needs to be addressed, though other social and health factors make 
obesity a complex and interesting issue for policy makers and people who manage the 
treatment (Mulvihill & Quigley, 2003). The public health white paper „Choosing 
Health (2004), devised following extensive consultation with the public and 
stakeholders, set a goverment focus for the first time ever on tackling the problem of 
obesity. One of the policies to implement included „specialist obesity services with 
access to a dietitian and advice and support on changing behaviour‟ (DOH, 2009) 
however following this agenda, recession has created economic downturn which has 
impacted on many services within the NHS and only one area within Liverpool was 
granted a budget to address this agenda.  
  .   
1.10 Patient Centred Approach 
Turning to the clinical and practice management of obesity, a patient-centred 
approach to treatment based on respect for and understanding of the patient and 
requiring the strong commitment of the patient is stressed. A structured system of care 
with long-term support and use of healthcare teams in primary care dedicated to 
obesity management and other disorders requiring similar approaches (e.g. 
hypertension care, smoking cessation), is proposed. However there is a lack of 
consistent weight management programmes within primary care settings (Mulvihill & 
Quigley, 2003). There is a need for consistent evaluation over a longer duration and of 
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publishable quality to identify a programme, which is most suited for the UK 
population and adaptable for regional variation.  
 In the subsequent literature review I discuss the best evidence regarding approaches 
to tackling obesity in a community setting.  
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Chapter 2  
Literature review  
 
The Foresight project „Tackling Obesities: Future Choices‟  (Foresight, 2007) has 
collated the existing evidence base of scientific research pertinent to obesity to give a 
platform from which to develop a long term vision for the public health response. 
This expands the more specific and focused reviews of the research evidence collated 
by NICE (2006). It is clear from the report there are many reasons why an individual 
may become obese and the current prevalence of obesity in the UK population is 
primarily caused by people‟s latent biological susceptibility interacting with a 
changing environment that includes a more sedentary lifestyle and increased dietary 
abundance. The specific causes at an individual level are many and varied and differ 
between population groups and across a person‟s life course, with the accumulation of 
excess fat, and therefore weight, being the end result of a variety of causal pathways 
(Foresight, 2007). During the course of the report a number of issues to facilitate 
obesity research were recurring themes for e.g. improving methodologies to measure 
diet and physical activity and development of detailed models to examine the future 
impact of obesity and its co morbidities (Foresight, 2007). 
 Wilding (2006) also described the state of the obesity epidemic and the profound 
implications for public health and emphasised „it is essential that any strategies 
adopted for treatment are directed towards those at greatest risk of the medical 
complications associated with the condition‟. Strategies which already exist include   
dietary, physical activity, behaviour modification, pharmacological and surgical 
weight loss methods with multi-component interventions being the treatment of 
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choice (NICE, 2006).  For the purpose of this literature search, existing weight loss 
methods and evaluation of weight management programmes will be reviewed.   
 
2.1 Dietary approach to weight loss 
 
The main requirement of a dietary approach to weight loss is that total energy intake 
should be less than energy expenditure (NICE, 2006). There is a wide-range of dietary 
interventions, shown to be effective in the treatment of obesity.  Avenell, Brown and 
Mcgee (2004) highlight existing evidence in support of 600Kcal deficit approach, low 
calorie, very low calorie and low fat diets as being most likely to be effective for 
modest weight loss. The same review  found a 600Kcal deficit approach with the aim 
of obese clients to lose 1-2lbs/ week (0.5-1kg), focusing on portion control, low fat, 
high CHO diet resulted in a mean weight loss of 5.32kg when following a calorie 
restricted diet (95% CI –5.86 to –4.75) with improvements in risk factors at 12 
months when compared to usual care. In the same review very low calorie diets under 
supervision produced greater short term weight loss (420 kcal/day for 8 weeks) which 
was shown in one study to cause significant weight loss, resulting in a body weight 
change of –13.40 kg (95% CI –18.43 to –8.37) compared with usual care (Avenell et 
al. 2004) although the relative effectiveness of clinically prescribed VLCD in the long 
term has shown weight regain is common.  
 
2.2 Measuring food intake 
Food intake is hard to measure,
 
especially in obese subjects (Seidell, 1998). 
Discrepancies of 22% between reported
 
energy intakes and measured energy 
expenditures (using the doubly
 
labelled water method) have been described in
 
obese 
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men and women using the food frequency questionnaire methods (Kroke et al. 1999).  
It is widely recognised subjects who are obese; misreport, the consequence being a 
complex pattern of partly inaccurate information (Winkler, 2005).  Despite limitations 
from using FFQ and 24 hr recall methods to collect diet history; in clinical practice it 
is not always feasible for patients to weigh foods.  Also dietary questionnaires which 
have been developed to measure nutrient intake via usual food consumption for use in 
large population studies (Kroke et al. 1999), can be subject to the effects of 
confounding (Margetts & Nelson, 1991). Estimates of nutrient intake are not always 
necessary to assess eating habits or to form the basis of sound advice, due to dietary 
advice being given in terms of foods, not nutrients. In 1999, Johnson, Hackett, Bibby 
and Cross assessed the face validity of a food intake questionnaire which is an 
adapted recall method collecting food-based data on the consumption of specific 
foods eaten on the previous day. Two hundred and twenty eight dietitians were asked 
to name foods they considered the most important when advising clients on four 
aspects of healthy eating. For example when lowering sugar intake eat less sweets and 
increase fruit consumption. Foods mentioned by most respondents in each category 
were ranked. The FIQ had face validity due to food items appearing in the list of 
ranked foods by more than 50% of the sample. More than half of the dietitian‟s 
considered 31 out of 56 foods where important when considering the four aspects of 
healthy eating. For this reason the FIQ is routinely used for assessing the eating habits 
of the Liverpool community and will be used during the evaluation process.  
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2.3  Physical Activity  
The health benefits of a physically active lifestyle are well documented and large 
amounts of evidence suggest regular activity contributes towards weight loss and is 
related to a lower incidence of many chronic conditions such as type II diabetes and 
cardiovascular disease (Shaw, Gennat, O Rourke, & Da, 2006) however it is not 
usually advocated as a sole treatment option (Wilding, 2006).  
NICE (2006) suggest incorporating physical activity into everyday life in the form of 
supervised exercise programmes or lifestyle activities including brisk walking, 
gardening or cycling although any physical activity should take into account a 
person‟s physical fitness and ability. The guidelines also recommend increasing 
activity for obese patients to double that of the general population to improve weight 
loss maintenance (NICE, 2006).  
Table 2.3a Physical activity guidelines for the general population, prevention of obesity and 
people who have been obese 
Type                          Time 
General population        30 minutes per day of moderate-intensity activity on 5 or more days a week 
To prevent obesity        45-60 minutes of moderate-intensity activity a day particularly if not reducing energy intake 
People who have been obese and have lost weight,  60-90 minutes of activity a day to avoid regaining weight  
 (NICE, 2006) 
 
A review by Shaw et al.(2006) concluded physical activity for a minimum of 
30 minutes three times a week resulted in a body weight change of –3 kg (95% CI –
4.00 to –2.18) compared with no treatment, at 12 months, this improved when 
 27 
duration of physical activity was increased. A number of other interventions have 
shown different ways of encouraging increased physical activity for the management 
of obesity. A review of systematic reviews and meta analyses by Bravata et al.(2007)  
demonstrated how using pedometers significantly increased physical activity in 
women over 49 years of age by 2491 steps per day more than control participants 
(95% CI, 1098-3885 steps per day, P<0.001). When data from this review was 
combined, pedometer users significantly reduced their body mass index by 0.38 (95% 
CI, 0.05-0.72; P =0.03). Although the positive outcome in the intervention was 
associated with older age, and having a step goal, pedometers appeared to motivate 
individuals to take part in physical activity, however more research is needed from 
weight management programmes which use pedometers. There appears to be lack of 
understanding as to the most appropriate level of exercise intensity needed to promote 
reasonable weight-loss. Walking is known to metabolise a high percentage of fat and 
is considered safe and sensible practice. However this results in small amounts of fat 
being oxidised due to the low metabolic demand of the exercise (Macfarlane & 
Thomas, 2009). Though a light exercise regimen is likely to be appropriate for those 
who are overweight or sedentary individuals beginning an exercise programme, the 
aim should be to gradually increase the work rate to moderate levels as their capacity 
or ability allows providing it does not compromise health. Indeed Shaw et al. (2006) 
concluded that vigorous exercise is more effective in causing weight loss than either 
moderate or light activity, but only when diet was not restricted.  
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2.4 Behavioural Therapy  
 
Behaviour strategies aim to help to reinforce changes in diet and physical activity for 
the treatment of adult obesity and require trained health professionals with good 
interpersonal skills to use the approach appropriately. A report by NICE (2006) 
recommends techniques using behavioural therapy, which have been developed to 
assist patients in conjunction with other weight loss approaches.  
 
Behavioural Interventions for adults should include the following strategies as 
appropriate per person.  
 Self monitoring of behaviour and progress 
 Stimulus control 
 Goal setting  
 Slowing rate of eating  
 Ensuring social support 
 Problem solving  
 Assertiveness  
 Cognitive Restructuring (modifying thoughts) 
 Reinforcement of changes 
 Relapse prevention  
 Strategies for dealing with weight regain  
(NICE, 2006) 
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No single method or combination of behavioural methods, prove to be clearly 
superior (Wilding, 2006). Thus, various strategies may be used to modify patient 
behaviour over the long term and such change can be achieved on an individual basis 
or in group settings.  
 It appears from research undertaken by Douketis, Feightner, Attia, and Feldman, 
1999 (as cited by Wilding, 2006) suggests combining behavioural approaches with 
more traditional dietary and activity advice, which may lead to improved weight loss 
during the initial 6-12 months and is currently the most effective lifestyle approach to 
managing weight. However these studies are of relatively short duration, therefore the 
evidence base is limited to one year.  
 
2.5 Combined approaches: Lifestyle interventions 
 
Despite clear guidelines being published (NICE, 2006) there are still many weight 
loss interventions which only offer a „quick fix‟ rather than a sustainable intervention 
to losing weight.  
 Multi-component interventions are the treatment of choice and programmes should 
include behaviour change strategies to increase physical activity levels or decrease 
inactivity, improve eating behaviour and the quality of the person‟s diet and reduce 
energy intake (NICE, 2006). The evidence for this approach is based on large multi-
component interventions which clearly demonstrate a combination of various levels of 
physical activity, behaviour therapy in different forms, and either a low-calorie or 
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calorie-deficit diet that can result in a body weight change of –4.22 kg (95% CI –4.80 
to –3.64) compared with no treatment, at 12 months (Shaw et al. 2006).  
 Large scale clinical trials have demonstrated the effectiveness of lifestyle 
interventions in specific groups of patients particularly those with impaired glucose 
tolerance who have achieved a modest weight loss of 5-10% from presentation 
weight. Weight loss mainly results in clinically worthwhile reductions in co 
morbidities such as type 2 diabetes, dyslipidaemia and hypertension reducing the 
overall risk of metabolic syndrome (Wilding, 2006). In the next section of this 
literature review, two european lifestyle programmes which address the benefits of 
weight loss to prevent type 2 diabetes and the complications associated with obesity 
including cardiovascular risk factors will be considered. 
2.6a PREDIAS (Prevention of diabetes self management programme) 
 „PREDIAS‟  is a lifestyle modification intervention and demonstrates the effects of 
weight loss for the prevention of diabetes. Inclusion criteria included adults aged 20-
70 years with BMI > 26kg/m
2
, with impaired glucose tolerance or impaired fasting 
glucose and an ability to read and understand German. Exclusion criteria were 
manifest diabetes or diagnosis of a serious illness e.g. cancer. Kulzer, Hermans, 
Gorges, Schwarz, and Haak (2009) randomised 182 male and female participants into 
a control or lifestyle modification programme. There were no significant baseline 
differences between those in the PREDIAS and the control group, 43% of the 
participants where female and mean age of the subjects was between 56.3+10.1 years,  
BMI (31.5+5.3 kg/m
2
) and fasting glucose 105.7+12.8mg/dl.  
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The prevention program consisted of 12 lessons lasting 90 minutes each. During the 
first 8 weeks, eight core lessons were given with one per week; the last four lessons 
were bi-monthly. The program is based on self- management theory and was 
conducted in small groups (median size seven people) and delivered by either diabetes 
educators or psychologists. Each participant received an exercise book, which 
contained information about diabetes prevention which contained resources such as a 
table of caloric values and worksheets e.g. eating diaries for each lesson. PREDIAS 
was compared with a control group whose members received written information 
about diabetes prevention and patient materials from the PREDIAS lifestyle 
modification programme. 
 
The aim of this study was to evaluate efficacy of PREDIAS with regard to the 
primary outcome variable (12 month follow up), weight reduction as well as 
behavioural, metabolic and psychological outcomes as secondary variables.  
Physical activity was assessed by a physical activity questionnaire used in a 
representative federal health survey in Germany. The Three factor eating 
questionnaire, with three scales cognitive restraint of eating, disinhibition, and hunger 
was used to measure psychological determinants of eating behaviour and anxiety was 
measured by the State Trait Anxiety Inventory. 
  The WHO Five well being index (WHO-5) assessed psychological well-being (low 
scores indicate reduced psychological well being) and the centre for Epidemiological 
Studies Depression Scale (CES-D) measured depressive symptoms (high scores 
indicate elevated depressive symptoms).   
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After 12 months, there was a significant effect on body weight. Participants in the 
intervention group had lost mean 3.8 kg of weight, whereas members of the control 
group had reduced their weight by 1.4kg (P=0.001). An intention to treat analysis 
yielded similar results (control group -1.3+3.9kg vs. PREDIAS group -3.6+5.1kg; P 
<0.001). A significantly higher proportion of weight was lost by those in the 
PREDIAS than those in the control group (−3.8 ± 5.2vs −1.4 ± 4.0 respectively; P = 
0.001). Similar results were obtained for BMI in control (−0.5 ± 1.4) and PREDIAS 
(1.3 ± 1.7). A between group value of (P = 0.002) was obtained for BMI, however 
discrepancies between these results were not discussed.  
Both groups increased their physical activity, but this was significantly greater in the 
PREDIAS than in the control group. Cognitive restraint of eating behaviour was 
significantly increased in the PREDIAS compared to control group, and eating 
disinhibition was significantly decreased in the PREDIAS than in the control group. 
Members of the PREDIAS group showed a significant within-group reduction on the 
hunger scale, but there was no significance between group difference (Kulzer et al. 
2009). There were significant effects on fasting glucose; however the 2-h postprandial 
glucose values did not change significantly between the groups. Total cholesterol and 
triglycerides as well as systolic and diastolic blood pressure, were significantly 
reduced in the PREDIAS group whereas in the control group there was no substantial 
change in these risk factors  
This study demonstrated significant weight loss. All measurement variables such as 
weight and clinical markers were clearly defined, however this could not be 
generalised to the UK population. The methods used for collecting data were valid 
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however the reliability of the hunger scale seemed ambiguous, the participants stated 
they were less hungry; however there was no explanation given for this finding, which 
suggests the sensitivity of the tool may have been reduced. There was also no 
explanation given for the non significant effect of weight loss on 2-h postprandial 
glucose values. 
2.6 Look AHEAD Study 
The look ahead study (Action for Health in Diabetes) conducted in the USA 
randomized 5,145 overweight and obese individuals with type 2 diabetes into an 
intensive lifestyle intervention involving group and individual meetings to achieve 
and maintain weight loss through decreased caloric intake and increased physical 
activity, this was compared with usual care diabetes support and education (Pi-
Sunyer, et al. 2007). Baseline characteristics included BMI >25 kg/m
2
 (>27 kg/m
2
 if 
taking insulin) and mean age > 40 years.  
The primary objective was to determine whether cardiovascular morbidity and 
mortality in individuals with type 2 diabetes can be reduced by long-term weight 
reduction, achieved by an intervention that includes diet, physical activity, and 
behavior modification including goal setting and maintain loss of at least 7% of initial 
body weight.   
Although one of the main objectives was to reduce weight, the overall aim was to 
reduce cardiovascular risk events thus an exercise test was performed on men and 
women with type II diabetes. Individuals not achieving criteria for age predicted 
maximal heart rate were not eligible for randomization into Look AHEAD. 
Sessions were led by intervention teams that included registered dietitians, behavioral 
psychologists, exercise specialists and lifestyle counselors. Participants were seen on 
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a regular basis in months 1-6 which included an individual session on the fourth week 
of every month. During months 7-12 participants continued to have a monthly 
individual meeting with their lifestyle counselor but the number of group sessions was 
reduced from three to two per month. 
A calorie restricted diet was the primary method of achieving weight loss. The 
macronutrient composition of the diet was structured to enhance glycemic control and 
to improve CVD risk factors. Participants were prescribed portion-controlled diets, 
which included the use of liquid meal replacements (provided free of charge) and 
frozen food entrées, as well as structured meal plans (comprised of conventional 
foods) for those who declined the meal replacements. Monthly reviews took place at 
an individual session to reassess progress.The physical activity program prescribed to 
the intervention candidates relied heavily on home-based exercise with gradual 
progression toward a goal of 175 min of moderate-intensity physical activity per 
week. Participants assigned to the intensive lifestyle program lost considerably more 
weight on average 8.6% of their initial weight vs. 0.7% in control group (P < 0.001). 
A significant relationship was observed between race/ethnicity and weight loss, as 
shown in figure 2.6c below.  
Figure 2.6c 
 
 
 
 
(Pi-Sunyer, et al., 2007) 
Percentage reduction in initial weight (in the ILI group) based on gender and ethnicity. ILI, intensive 
lifestyle intervention 
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A one way ANOVA revealed that the four ethnic groups all differed significantly (P < 
0.001) from each other, but there was not a statistically significant ethnicity-by-
gender interaction. Weight losses achieved in this study demonstrate the wide-scale 
acceptability of Look AHEAD‟s lifestyle intervention. Smaller weight losses in 
groups other than Hispanic white may have been attributable to a variety of non-
treatment-related factors and significant economic barriers (e.g., lack of 
transportation). This finding in relation to UK weight management interventions 
demonstrates the difficulty for programmes to achieve a 5-10% weight loss in all 
subsets of a demographically and ethnically diverse population,   
There were greater reductions, in diabetes, hypertension, and lipid-lowering 
medicines when compared to control participants. Mean HbA1C dropped from 7.3% 
to 6.6% in Intensive LI (P < 0.001) vs. from 7.3 to 7.2% in DSE. Systolic and 
diastolic pressure, triglycerides, HDL cholesterol, and urine albumin-to-creatinine 
ratio improved significantly more in intensive than control participants (all P < 0.01) 
  (Pi-Sunyer et al. 2007). 
 This study‟s principal finding was that an ILI induced a clinically significant weight 
loss in all subsets of a demographically and ethnically diverse population which is 
more reliable than the PREDIAS study due to sheer sample size and large 
improvements in cardiovascular risk factors. A standard method for measuring energy 
expenditure was used METS (metabolic equivalent tasks). For example one MET is 
the energy expenditure and caloric requirement at rest, METS increase depending on 
level of activity which is important for reliability purposes and similar to the UK 
equivalent PAL (Physical activity level). However the results cannot be generalised 
due to the intensity of the programme and the use of liquid meal replacements. Meal 
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replacements are not a sustainable lifestyle change for weight loss but are useful for 
rapid weight loss in morbidly obese patients. Continued intervention and follow-up 
will determine whether changes are maintained and overall CVD risk is reduced in the 
same participants.  
 
 Although weight loss was solely for treatment purposes in both studies and the 
magnitude of these effects could not be generalised to UK population, observed 
metabolic change recognise that weight management does not cease at the end of the 
weight loss phase (6 months for most people) and ideally a structured maintenance 
phase should be implemented after 6 months to maintain this level of metabolic 
change in order to prevent diabetes and CVD.  
 
2.7 Evaluating weight management programmes in the UK 
Evaluation is particularly important in the area of UK interventions that aim to tackle 
the issue of overweight and obesity. The National Obesity Observatory (2009) state 
there is a lack of high quality evidence on effective weight management interventions 
in the UK, with many being of short duration, with little or no follow up. 
 Other studies found that whilst interventions are being commissioned by a variety of 
organisations, data informing the relative „success‟ of the interventions, in terms of 
the intended health outcomes are patchy and inconsistent, (Aicken et al. 2009). In 
light of this finding the national obesity observatory (NOO, 2009) produced a 
standard evaluation framework (table 2.7b). The aim of the framework is to support 
high quality, consistent evaluation of weight management interventions in order to 
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increase the evidence base. This should ensure core information is collected in a 
standardised way across the country, helping to increase our understanding of the 
impact of individual intervention programmes (NOO, 2009).  
 
The essential criteria (marked x) for a successful weight management evaluation are 
as follows:  
Table 2.7b: NOO (2009) core elements of standard evaluation framework 
(Criteria adapted) 
Demographics of individual participants                                                         Essential 
27. Age                                                                                                                       x 
28. Sex                                                                                                                        x 
29. Ethnicity                                                                                                               x 
30. Disability                                                                                                              x 
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31. Measure of socio-economic status                                                                 x 
32. Additional information including marital status, medical history.  
smoking status, parity and family make-up                                                         x 
33. Details of parental weight status (for children) 
Part three: baseline data                                                                                   x 
34. Height and weight (to calculate Body Mass Index)                                      x 
35. Additional proxy measures for adiposity 
36. Measure(s) of dietary intake and behaviour                                                 x 
37. Measure(s) of physical activity levels and behaviour                                  x 
38. Potential facilitators of, and barriers to, lifestyle change 
Part four: follow-up data  Impact evaluation                                                 x 
39. Follow-up data: minimum of three follow-up points,                                   x 
including at one year                                                                                                   
40. Follow-up data on key measures (height, weight, physical       
activity and diet) over a greater term than one year                                           x 
41. Height and weight (to calculate Body Mass Index)                                     x 
42. Follow-up data on additional proxy measures for adiposity 
(if collected at baseline) 
43. Dietary intake and behaviour                                                                        x 
44. Physical activity levels and behaviour                                                                  
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45. Follow-up measures on potential facilitators of, and barriers to,  
lifestyle change (if collected at baseline) 
Process evaluation                                                                                             x 
46. Number invited                                                                                             x 
47. Number recruited                                                                                          x 
48. Number attended each session or contact point                                           x 
49. Number completed                                                                                       x 
50. Number of participants at each follow-up point                                           x 
51. Methods of data collection and timings 
52. Reasons for opt-out (where applicable)                                                        x 
53. Details of any unexpected outcomes and/or deviations from the 
intended intervention design and the reasons why 
54. Participants‟ satisfaction with the intervention                                             x 
55. Plans for sustainability 
Part five: analysis and interpretation                                                                   x 
56. Summary of results compared to baseline 
 (for primary and secondary outcomes)                                                              x 
57. Details of any further analyses and statistical methods  
58. Limitations and generalisability 
(NOO, 2009) 
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Though the framework is clear and consistent, clinical risk factors particularly in 
adults should be collected if available for e.g. lipids. If this data is available to 
clinicians: information can be collected at baseline with other co-interventions such as 
anti-hypersensitive drugs which may also influence outcome in the long term 
(Douketis, Macie, & Thabane, 2005). At follow up, the effects of weight loss on CVD 
risk factors can then be compared.  
2.8 Health Related Quality of life  
Another important outcome for weight loss programmes is health related quality of 
life, obese people suffer prejudice, discrimination and stigmatisation at all levels of 
social functioning with psychological distress occurring not only as a result of the 
negative reactions of others but failed attempts at weight loss (Ross, 1994).  A study 
evaluating the association between quality of life (health related utility) and obesity in 
hospital treated people with diabetes and no diagnosed diabetes was conducted in 
Cardiff by postal questionnaire to 27 924 patients.  Lee et al. (2005) found increasing 
BMI reduced utility in all three groups, BMI was significantly greater for those with 
type 2 diabetes (P<0.001). This study concludes obesity negatively impacts upon 
health related utility and thus quality of life for all patient groups, thus EQ5D is a 
useful tool for weight management programmes measuring changes at baseline and 
subsequent follow up. 
 
2.9 Counterweight Programme 
The Counterweight programme is the only fully evaluated evidence based primary 
care weight management programme in the UK (Counterweight, 2008). Adult patients 
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were offered counterweight if they had a BMI >30 kg/m2 or 28 kg/m2 with obesity 
related co morbidities and in the contemplative or action stages of change.  
(Prochaska & Diclemente, 1983).  
 Weight management advisers and dietitians led and facilitated implementation of 
counterweight, offering expertise in obesity management, providing materials and 
training for practice nurses from 65 UK general practices. Practice nurses delivered 
patient education using published materials and asked patients to commit to nine 
appointments in 12 months after initial screening. First-line interventions included six 
individual appointments (10–30 minutes each) in which a prescribed-eating plan was 
administered, or six group sessions (1 hour each) over a 3-month period (exclusively 
goal setting). Patients were then followed up at 6, 9, 12, 24 months and aimed to 
achieve an energy deficit of ≥500 kcal/day.  The counterweight team planned 3-month 
reviews in session 6 of the intervention. 
If weight loss of >5% was not achieved at 3 months patients were eligible for 
pharmacotherapy. Nurses delivered interventions to 1906 patients with the majority 
having severe obesity. Mean age for patients at baseline was 49.4 years (SD 13.5 
years, range 18.1–76.0 years) with 77% of the intake being female. At follow up 
primary outcome measures include weight changes at 12 and 24 months and 
percentage of patients achieving and maintaining 5% loss at these time points. 
Secondary outcomes were changes in clinical biochemistry. There were high levels of 
attrition at twelve and 24 months (825 patients). For data that was available mean 
weight change was considerably lower (–3.0 kg (95% CI = –3.5 to –2.4 kg) and at 24 
months was –2.3 kg (95% CI = –3.2 to –1.4 kg). Over a quarter of patients had 
maintained weight loss of 5% at 12 months and 24 months. Cardiovascular risk 
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factors were greatly improved at 12 months including a reduction in total-cholesterol 
–0.29 mmol/L (n = 303, P<0.001); low-density lipoprotein cholesterol –0.35 mmol/L 
(n = 172, P<0.001); HDL-cholesterol +0.03 mmol/L (n = 234, P = 0.08); systolic 
blood pressure –2.03 mmHg (n =580, P = 0.01); diastolic blood pressure –1.15 mmHg 
(n = 580, P = 0.01), and (in patients with diabetes only) HbA1c –0.19%(n = 93, P = 
0.17); and fasting glucose+0.08 mmol/L (n = 28, non-significant).  
These results demonstrate Counterweight is an effective programme offering ongoing 
support with realistic weight loss goals. The intervention can be generalized to UK 
patients due to the large sample size and UK based practices. Importantly the results 
showed patients were monitored throughout and the effects of treatment certainly 
improved risk factors. The use of onscreen alerts to remind of patient appointments 
was useful.  It was unclear why attrition rates were so high at twelve and 24 months 
and why there was a higher ratio of women to men (Counterweight, 2008). Other 
small scale studies have evaluated weight management programmes run by health 
visitors (Muckle, 2007) some of the recommendations for practice after conducting 
interviews included. 
 
 Obesity management could mirror smoking cessation services by assessing 
individuals readiness to change and making services available for those who 
are motivated 
 Education should address attitudes towards obesity; it should be managed and 
treated as a chronic condition. 
 Specialist services should include support groups, counselling or cooking 
skills courses according to individual need. 
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 Easier access to physical activity, specifically for those who are overweight or 
obese because they felt too self conscious to attend mainstream services.  
(Muckle, 2007) 
 
Taking the above into consideration it is also apparent men are more reluctant to 
engage in weight loss programmes. Gray et al. (2009) addressed this problem by 
evaluating a group based weight management intervention based on the Camelon 
model specifically developed for men. The programme was a success as the majority 
of obese men 76.2% who enrolled in a weight management group completed the 12-
week programme: of these, 44.3 % achieved ≥5% weight loss. The model was 
particularly useful at engaging hard to reach men by making them aware of health 
risks and being described as „obese‟. The humour, rapport with nurses, other men, 
positive food and exercise choices were some of the reasons why they decided to 
continue with the intervention (Gray et al. 2009).  
2.10 Group programmes versus one to one care  
 
In response to the obesity epidemic, the weight management field has changed 
dramatically over the last ten years and there is now an urgent need for the dietetic 
profession to consider whether current approaches meets this changing agenda and to 
examine how to best utilise time and expertise (DOM UK, 2007).  As discussed in the 
literature, guidelines for weight management recommend energy restriction, 
combined with increase in exercise and behaviour therapy.  Also disease management 
styles, which centre around the patient and their goals have resulted in better 
adherence to treatment protocols, reduced morbidity and improved (HRQL) health 
related quality of life (Bauman, Fardy, & Harris, 2003). Little evidence exists when 
 44 
comparing one to one care to group based sessions for weight management.  A study 
by Ash, et al. (2005) randomised a total of 176 adults with a BMI of 27 kg/m2, (mean 
age 48 years, mean BMI 34+5.5 kg/ m2) into cognitive behaviour therapy, 
individualised dietetic treatment and information booklet only. The aim of this study 
was to demonstrate that group therapy is more effective at reducing weight and other 
weight variables, increasing activity and improving health and well being when 
compared to other treatment interventions. A statistically significant difference 
between groups was observed for weight change over time (P< 0.05). The change in 
weight  for group therapy was significantly greater than the book only group at 3 and 
12 months (2.87+0.7 compared to -1.7+0.6 kg, P<0.05 and  -2.9+0.9 compared to 
+0.5+0.9 kg, P<0.005, respectively). Though changes in weight did not differ at any 
time point except when compared to the book only intervention, the group 
intervention was shown to be as effective as individualised dietetic treatment and 
more cost effective as the intervention is dealing with more patients over a set time 
period (Ash et al. 2005).  
 A more recent evaluation by Hickson, Macqueen and Frost (2009) collected data on 
consecutive obese patients, attending either and intensive weight management clinic 
(IWMC) or a general dietetic outpatient clinic. The IWMC had a structured approach 
with six once-a-month appointments, a signed agreement to attend, an initial 
screening of readiness to change and consistent advice from one dietitian. The general 
clinic was less structured, had more ad hoc follow up and did not guarantee one 
dietitian. The majority of patient‟s refered were female with a mean age of 48 years. 
Thirty-three percent (103/313) of all patients referred did not book an appointment. 
Of those attending with a body mass index 32 kg m
2
, 55% were seen in the general 
and 45% in the intensive clinic, but only 19% and 53%, respectively, completed the 
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programmes. The total amount and rate of weight loss did not differ significantly 
between clinics. However, analysis using the last recorded weight revealed a median 
weight reduction of 1.8% (interquartile range =  5.6) at the median rate of 0.4 kg per 
month in the intensive clinic, compared to no overall weight loss in the general clinic 
(P < 0.001).In conclusion to this a more structured approach and initial screening of 
readiness to change is likely to achieve better weight loss results and therefore will 
comprise a better use of dietetic time than including obese patients in general clinics.  
 
2.11 Evaluation aims and research questions  
Aim 
The aim of this evaluation was to evaluate the introduction and impact of a specialist 
obesity service by testing the following null hypothesis and further research questions  
Null Hypotheses 
Hypothesis 1: Patient‟s six clinical outcomes including body weight, BMI, lipids, 
fasting blood glucose, Hba1c (if applicable) and blood pressure did not change while 
taking part in the first three months of a specialist obesity treatment service.  
Evaluation Questions 
 Are patients reported food choice, self-esteem and HRQL improved as a result 
of the specialist obesity treatment service?  
 Do patients attending the group programme lose more weight and improve 
clinical outcome when compared to „usual one to one dietetic practice‟?  
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Chapter 3  
Methods  
 
The design was a non-experimental pre and post evaluation of a new specialist weight 
management service which included usual care dietetic clinics and 12 week group 
programmes provided by the department of community Dietetics, Liverpool 
community nutrition and dietetics.  
  
The evaluation included two phases: the intensive phase was integrated in the first 6 
months of the weight management programme and follow up phase 6 months after. 
This was a pre and post analysis of primary data obtained from patients at baseline 
and 3 months including biochemical data which was ready available from G.P. routine 
health assessments during the intensive phase of this programme Questionnaires to 
measure diet, health related quality of life and self esteem were completed at baseline 
and 3 months in addition clinical variables were recorded if applicable.  
 
3.1 Population and participants  
 
This study used a convenience sampling technique, which focused on all patients 
routinely referred for dietetic advice for obesity by their GP or other health 
professional who met the inclusion criteria. The inclusion criteria included patients 
with a BMI of 30+ with or without comorbidities (comorbidities included high blood 
pressure, raised lipids or diabetes) and those treated with weight management 
medications including Orlistat.  The principal exclusion criteria included BMI below 
30; pregnancy or diagnosis of proven eating disorder: anorexia nervosa or bulimia.  
 
 47 
The programme consisted of an intensive phase (0-6months) of which this evaluation 
reports (0-3 months) and a follow up phase 6-24 months. During the intensive phase 
patients attended an initial assessment clinic with a specialist weight management 
dietitian. At the assessment clinic patients chose one of two treatment options: either a 
12-week group education programme and dietitian or 4 monthly individual one to one 
review appointments with the dietitian.  
 
The criteria for exclusion from the data analysis included patients who did not attend 
their assessment clinic, did not attend their 3 monthly follow up, when data was found 
to be unavailable or the patient did not agree to take part in the evaluation. 
 
3.2 Step by step group sessions 
The sessions were based in Liverpool community health premises and local health 
centres across Liverpool. This evaluation used the existing clinic network to see 
patients, conduct assessments and review appointments.  
 Step by step is a new specialist obesity service, which specifically targets obese 
patients at greatest risk of further ill health due to their weight. Only patients who 
were referred routinely by their GP or health professional have been included in the 
service evaluation. Patients had the option to accept or decline treatment with the 
service after referral from their GP.  All patients receive a service leaflet, which 
includes information about the dietetic service, their treatment and right to consent to 
be seen by a dietitian. They were informed that their agreement to attend the initial 
appointment with the dietitian constitutes consent for treatment. Patients are asked to 
consent to attend weight management groups if they agreed to take part. At their first 
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clinic appointment, the senior specialist dietitian completed a dietetic assessment and 
agreed a specific programme of treatment based on the patients needs. 
 
The programme includes individual care or weight management group sessions. The 
weight management service aims to offered patient‟s initial assessment, group 
sessions, long-term support for losing weight over a two-year period and manage any 
other medical problems. The service evaluation will be used to enable the dietetic 
department to investigate and develop a range of treatment options for patients who 
are obese. 
 
At present weight management groups and individualised care conducted by the 
community dietitian‟s. Referral to the multidisciplinary team is offered to patients 
with little or no evaluation therefore it is difficult to formalize the range of treatment 
options. In terms of time and cost the group education sessions allows more 
individuals to access a dietitian for a longer period of time, while reducing waiting 
lists. The evaluation will formalize the range of treatment options offered to patients 
with severe obesity. The design and scope of the evaluation was based on staffing 
levels and evidence based practice. No patients referred at this stage of care were 
placed at any disadvantage, and all patients meeting referral criteria had the option to 
be seen in the new expert weight management service model, or be seen in the usual 
way which enabled support based on individual choice.  
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3.2a Group programme 
The 12-week group sessions were based on best practice, which deliver diet, 
behavioural approaches and incorporate physical activity for the treatment and 
management of obesity. The session topics include diet: fats, sugars, fibre, portion 
control, food combination, food labels, cooking skills and shopping skills.  
 From a behavioural aspect, sensible target setting and motivational support skills 
were included. The community food worker team (members of the dietetic team) 
delivered 4 practical cooking sessions as part of the group education programme, this 
included one session on the „eat-well plate‟ and meal planning. The cook and taste 
sessions aimed to improve patients knowledge surrounding diet and health by cooking 
healthier foods which are lower in fat, sugar, salt and higher in fibre. During the 
community food worker session‟s patients were given practical tips on food portions, 
consumption of fruits and vegetables, water consumption, alcohol, eating out and how 
to eat healthier and cheaper as well as building physical activity into daily life.  
 Recommendations for physical activity are discussed in detail with the benefits of 
physical activity and common barriers explained. There is also the opportunity for 
patients to sign up to „walk for health‟ which is a collaborative scheme run by 
Liverpool PCT which aims to increase physical activity levels. On joining „walk for 
health‟ and after five supervised walks patients receive a free pedometer and gym 
pass for one month‟s period. Service information leaflets are also provided to explain 
and reinforce messages, which include  „Step by Step‟ and „Bag a good meal‟ 
publications created by the Liverpool community dietetic department, which have 
been developed with local people in mind.  
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  Patients received a baseline health assessment and were routinely weighed at the 
same time every week for 12 weeks. During the follow up phase (6-24 months) 
patients are offered a further 4 assessment clinics with a specialist dietitian at 6, 12, 
18 and 24 months.  
 Further specialist support from the multi-disciplinary team is available when required 
including e.g. advice on obesity medication, physiotherapy or pyschological support 
will be referred as appropriate. In addition ongoing support will be available to 
patients who have the opportunity to access fortnightly weigh in clinics, and practical 
activities from members of the dietetic team through out the two- year period.  
 
3.3 Measurements  
Independent and dependant variables  
In this study it was important to collect demographic information on gender 
(male/female), age (years) and location of health centre visited, which helped provide 
some characteristics of participants at baseline.  
The independent variables in this evaluation included the „one to one clinic‟ and „12 
week weight management programme‟ with subsequent follow up one to one reviews.   
The dependant variables included changes in weight/kg, BMI, lipid 
(cholesterol/mmol, LDL/mmol, HDL/mmol), fasting blood glucose/mmol, HbA1C/%, 
blood pressure/mgHg, food intake, self esteem (Rosenburg, 1979) and health related 
quality of life (Euroqol, 2010).  
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3.4 Clinical outcomes 
The following six clinical outcomes were measured: body weight, BMI, lipid profile, 
fasting blood glucose, HBa1c (if appropriate) and blood pressure was extracted from 
patient case notes on referral and compared from baseline to 3 months to identify 
changes within this period. These outcomes were selected because they are objective 
and indicative of a reduction in obesity related risks associated with weight loss, also 
they represent the most common comorbidities which GP‟S referred to the service.  
All measurement‟s, including weight and BMI were recorded by a registered dietitian 
using standardised methods. Weight was measured to the nearest 0.1kg.  Patients were 
measured in light clothing without shoes. Height was measured in meters using a 
freestanding height measure (Leicester Portable Height Measure (SE001 by SECA). 
Body mass index was calculated using the formula weight (kg)/ height (m
2
).  
Biochemical measurements were recorded routinely by a G.P as part of the referral 
process, were available or could be requested with consent from the patient‟s from 
their medical records, (stored in a secure unit at Abercromby Health Centre).   
Three validated questionnaires were used. The first questionnaire measured dietary 
intake (Johnson et al. 1999). Self esteem (Rosenburg, 1979) and quality of life 
(Euroqol, 2010). 
 
3.5 Food Intake questionnaire (appendix 7.1) 
The food intake questionnaire (FIQ) is an epidemiological tool for assessing eating 
habits. It is an adapted recall method, which collects food-based data on the 
consumption of specific foods eaten on the previous day. Using a food based 
approach to measure intake is consistent with the way messages on healthy eating are 
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delivered and the items included have shown to be representative of the general 
advice given by dietitians in terms of foods to eat more or less of to achieve a healthy 
diet. The FIQ provides information on food intake at the group level and was not 
designed to estimate nutrient intake. The FIQ asks basic questions: „Did you at any 
time yesterday eat any amount of…‟ The question is then followed by a list of food 
related items. The main outcome variables are the number and proportion of adults 
answering yes and no to specific FIQ items (Johnson et al. 2001) 
 Foods can be aggregated into groups including positive and negative marker foods. A 
score is then given for each individual providing a mean score for groups based on 
gender, age and area.  
 
 
3.6 Rosenburg self esteem scale (appendix 7.2) 
 
The purpose of the 10 item RSE scale is to measure self-esteem and can been used 
with a variety of groups including adults.  Scoring involves a method of combined 
ratings. Low self-esteem responses are “disagree” or “strongly disagree” on items 1, 
3, 4, 7, 10, and “strongly agree” or “agree” on items 2, 5, 6, 8, 9.  
The RSE demonstrates a scale coefficient of reproducibility of .92, indicating 
excellent internal consistency. For validity purposes the RSE is concurrent, predictive 
and construct validity using known groups. The RSE correlates significantly with 
other measures of self-esteem. In addition, the RSE correlates in the predicted 
direction with measures of depression and anxiety (Rosenburg, 1979). 
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3.7 EuroQol (appendix 7.3) 
EQ-5D (2010) is a standardised instrument for use as a measure of health outcome. 
Applicable to a wide range of health conditions and treatments, it provides a simple 
descriptive profile and a single index value for health status. EQ-5D is designed for 
self-completion by respondents and is ideally suited for use in postal surveys, in 
clinics and face-to-face interviews. It is cognitively simple, taking only a few minutes 
to complete. Instructions to respondents are included in the questionnaire (Euroqol, 
2010). 
 
3.8 Referral process  
All patients meeting the referral criteria who have indicated that they would like to 
attend the programme will receive an appointment letter for the expert weight 
management assessment clinic. At this appointment patients will be asked to read a 
participant information sheet (Appendix 7.4) which, contain details of the service 
evaluation, attached to this is a consent form (Appendix 7.5). If a consent form has 
been signed questionnaires can then be administered to the patient in the first routine 
care clinic or first week of the group education sessions. Once the questionnaire has 
been completed it can be returned the lead dietitian, this process is repeated after three 
months in both cases for the purposes of this evaluation only.  
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3.9 Confidentiality  
 
Patient‟s clinical records and data including questionnaires were stored in accordance 
with Liverpool Community Health clinical governance procedures. Only the 
researcher and dietitians in the direct healthcare team involved in assessment and 
treatment had access to personal/ clinical data. After data collection; data was 
anonymised using a unique reference number for each patient prior to inputting into 
data files to maintain confidentiality. For all subsequent analysis patient‟s clinical 
records and personal details were stored separately to data collected. All electronic 
data was stored on Liverpool Community Health secure network.  
 
Information collected for analysis procedures, was stored securely on the hard drive 
of a HP Pavillion. The computer was ID and password protected and only available to 
the main researcher. 
 
3.10 Ethics  
 
Ethical approval was by the NHS National Research Ethics Service (Appendix 6.7). 
Minor adjustments were made to the participant information sheet in response to the 
committee which included rearranging of sentences. This was submitted and data 
collection commenced. A pilot study was necessary to test logistics and gather 
information prior to data collection for the evaluation (see appendix). Careful 
arrangements were in place to obtain informed consent, patients who gave consent for 
their data to be part of the evaluation were protected under the „The Caldicott 
principles‟ for handling data, Data Protection act (1998) and the NHS Code of 
confidentiality which ensures patient information is held under legal and ethical 
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obligations of confidentiality in which information provided in confidence should not 
be used or disclosed in a form that might identify a patient without his or her consent.  
 
The evaluation used data, which was routinely collected by health practitioners as part 
of their normal care of the PCT, therefore no additional measurements were taken 
during baseline and follow up. Patient clinical data was collected from medical 
records and questionnaire data was then transferred onto a secure database.  There 
were no potential risks or burden involved when completing the questionnaire 
however the quality of life and self-esteem questionnaire contain questions of a 
sensitive nature. Such questions are routinely asked as part of the usual clinical 
dietetic assessment process therefore it was felt this would not affect or bias the data 
collected. Any potential issues arising from sensitive questions, the weight 
management service has access to pyschological support from Liverpool PCT‟s 
counselling service (The dietetic department became part of NHS Community Health 
during this evaluation).  
All patients who received an appointment letter for the weight management 
assessment clinic received service information leaflet explaining the dietetic treatment 
process and could consent to or decline treatment from the service at this point. If a 
patient consented to attend the dietetic clinic or dietetic lead weight management 
group programme a separate information sheet and consent form was administered for 
the purposes of the evaluation. If a patient decided not to take part in the evaluation 
the participant would be withdrawn from the study and therefore continue with 
treatment as usual.  
The information sheet was written in non-technical terms explaining the aims and 
objectives of the weight management evaluation with further contact details for the 
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lead researcher.  It was made clear that treatment choice is not part of the evaluation; 
all that was required was data collection.  
The questionnaires are completed by patients at their first clinic or first week of the 
group programme. Before the questionnaires were administered they are stapled 
together to ensure patients completed all three tools, furthermore the questionnaires 
were counted after administering to ensure patient confidentiality.  
 
 
3.11 Statistical analysis  
Data was analysed using SPSS version 17 (2010) All data was coded before analysis.  
 
To test the null hypothesis mean changes in weight, BMI, lipids, fasting blood 
glucose, Hba1c (if available) and blood pressure at baseline and follow up (3 months) 
were compared using paired t-tests. A result providing a significance level of P less 
than or equal to 0.05 was deemed to be statistically significant. 
Nominal FIQ questionnaire data is presented as percentages or frequencies. Diet data 
were analysed using chi-square to detect associations between intake of specific 
foods. Independent sample t test were performed to compare differences between 
mean food group score between gender at baseline and three months. A paired t test 
was used to evaluate changes in self esteem and HRQL at baseline and follow up
                
Chapter 4: RESULTS 
Patient flow from initial contact through to evaluation completion is shown in fig. 4.1. A total 
of 50 patients were referred by their general practitioner to the specialist weight management 
programme, between September 2009 – February 2010 of which, 41 returned to follow up at 
three months (November 2009 – July 2010). The remainder (n=9) did not attend or were 
followed up at different time points. Anthropometric data were available for 35 patients and 
33 patients completed food intake data at week 1 and week 12. In total 12 patients had 
clinical biochemistry compared pre and post intervention.  
 
Figure 4.1: Process identifying number of patients at each stage of the evaluation. 
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4.2 Pre intervention characteristics  
Pre intervention data are presented in table 4.2. The data (male 19, and female 31) are 
presented as Mean ± S.D. Mean age for patients at the start of the programme was 59 years.  
62 % were female and of those who took part in the programme, obesity was severe (mean 
weight for males 113.5 kg/m
2
, BMI 39.3 kg/m
2
 and mean weight for females 92.7kg/m
2
, BMI 
36.5 kg/m
2
).  
 4.3 Clinical data 
 Clinical outcome data were available for 25 patients, who had been routinely referred by 
their GP. These patients were referred for weight management advice and all had additional 
co-morbidities. Of the 25 patients, mean values for total cholesterol were less than 5mmol/L, 
mean LDL (low density lipoprotein) was under <3.0mmol/l for males, and above optimal 
levels for females (3.17mmol/L). Mean TG was elevated in males (>2mmol/L).  
 Mean results for fasting blood glucose (FBG) were within the normal range for males 
(<5.6mmol/l), a higher mean result for females (6.58mmol/l) indicated impaired glucose 
tolerance (table 4.3a). In both cases, 7 patients were already diagnosed with diabetes. A high 
HbA1C was recorded in 1 female diabetic patient >7.5% however this result differed between 
all diabetic patients and would not be used to determine improved HbA1C at 12 weeks due to 
insufficient data.  Patient blood pressure was also monitored by their G.P., mean systolic 
blood pressure was above 120 mmHg for 10 patients out of 13 patients (77% of patients), 
looking at this data in detail one patient‟s reading was above 170mmHg indicating some 
patients had severe hypertension on referral to the weight management programme.    
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4.4 Pre intervention questionnaires 
In all, 46 patients completed a food intake questionnaire, 32 patients completed the 
Rosenburg questionnaire and 44 patients completed the EQ5D correctly. Incomplete 
questionnaires were not inputted during the evaluation period.  
 
 
Table 4.3a : Mean ± S.D values of anthropometry and biochemistry measures pre intervention 
                  Male               Female  
 n 
19 
Mean.  S.D n 
31 
Mean  S.D. 
Height 
(m) 
17 1.71 ±. 07 
 
.07 17 1.6  
 
.056 
Weight     (kg)  19 113.45  
 
20.80 29 92.62  
 
12.95 
BMI (Kg/m
2
) 18 39.3  
 
6.40 26 36.5  
 
6.20 
Total Cholesterol 
(mmol/L) 
14 4.76  
 
1.00 9 4.92  
 
.87 
HDL 
(mmol/L) 
13 1.13   
 
.18 8 1.16   
 
.31 
LDL 
(mmol/L) 
11 2.6   
 
.89 7 3.17   
 
.80 
TG 
(mmol/L) 
13 2.52  1.81 7 1.91 
 
 
.83 
FBG 
(mmol/L) 
9 5.43  ±1.05 
 
1.05 4 6.58  
 
.68 
HBA1C 
   (%) 
4 
 
6.08  
 
1.08 3 7.17  
 
.40 
SBP (mmHg) 9 140.6  
 
16.74 4 131.8  
 
12.28 
DBP (mmHg) 9 80.8   
 
5.16 4 73.8  
 
4.92 
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4.5 Post programme results (12
th
 week of the weight management programme) 
Forty one patients (82 %) returned to follow up at 12 weeks. Nine patients did not attend 
(DNA).  
4.6 Changes in Weight and BMI  
Mean weight at three months ranged from 89 kg to 136 Kg for males and 66.6kg to 128 kg 
for women. Table 4.6a presents mean weight changes at three months.  A paired sampled t 
test was conducted to evaluate changes in the mean body weight for all patients. Mean weight 
change (chart 4.6b) was approximately 1.99 kg (95% CI 1.12- 2.86). Mean change in BMI 
(chart 4.6c) at three months was 0.66kg /m2 (95% CI, 0.21-1.10). Participants who attended 
the specialist programme showed a significant weight loss (P<0.05) and lower BMI (P<.005) 
during the intensive period (0-3 months).  The percentage weight loss for males was higher 
(3.4%) than females (1.5 %).  
Table 4.6a: Mean values for weight, height and BMI at the start and end of the programme 
for male and female 
 Program Start 
(n=) 
 
Programme end 
(n=) 
 
 
Mean difference 
for weight and BMI 
 Male               Female  
 
Male  Female  Male  Female 
Weight (kg) 113.44 92.62 109.54 91.25 -3.9kg  -1.4kg 
BMI (kg/m
2
) 39.25 36.45 37.69 36.09 -1.6 -0.35 
Overall 28 patients lost weight, 5 patients stabilized and two patients gained weight at 12 
weeks 
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4.6 b+c Paired t-test data 
 Compared mean values for weight and BMI at the start and end of the programme for all 
patients.  
Chart 4.6b         Weight (kg)                                          Chart 4.6c         BMI  
 
 
 
 
 
 
An independent samples t test was used to explore mean weight change between males and 
females. Male patients lost more weight during the intense phase of the programme, 2.5kg > 
than females (P<.001) however a significant weight loss result was observed (P<.005) for 
both males and female at twelve weeks.  
 
4.7 Changes in blood pressure and clinical biochemistry  
Table 4.7a presents patient blood pressure and biochemistry at the start and end of the 
programme. The changes in mean total cholesterol, HDL, LDL, TG, FBG and blood pressure 
were compared using paired sample t tests. Only data which was retrievable from patients 
who were routinely monitored by their G.P was used in the evaluation.   
 
Mean 
Kg   
Mean 
Kg 
/m2 
Weight: pre 
intervention 
 
 
 
BMI: pre 
intervention 
 
 
 
Weight: post 
intervention 
 
 
 
BMI: post 
intervention 
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4.7 Paired t test data for clinical biochemistry and blood pressure 
* several patients were compared to pre intervention test results  
Twelve patients had clinical biochemistry and blood pressure measures to compare pre 
intervention. Several patients values were compared with FBG values.  All values were non 
significant post intervention, however changes were observed at three months for blood 
pressure. Although non significant, SBP dropped from 134.7 to 131.7, significant changes 
were observed for DBP (mmHg) at twelve weeks (P<0.025). 
 
 
4.8 Food Intake results  
   The analysis of the diet data was presented as chi
2
 for all subjects, males and females could 
not be analysed separately due to the small sample. Thus data are presented as percentages.  
Mean intake of positive and negative marker food group‟s pre and post intervention were 
analysed using paired t-test (positive and negative foods, appendix 9.2pp111).   
Table 4.7a:  Mean values of biochemistry measures at the start and end of the programme. 
Parameter  Program  
Start 
      Mean  
 
(S.D.) Program 
Finish 
Mean  
        (10) 
(S.D.) 95% CI 
 
 
 
Lower        Upper 
P-value 
Total Cholesterol  5.09  1.39 5.05 1.37 -.9097 .9897 NS 
HDL 1.23 .23 1.2 .27 -.0526 .1193 NS 
LDL 2.8    .92 3.06 1.45 -1.47 1.11 NS 
TG 1.72  1.54 1.72 .78 -.72 .32 NS 
FBG*  5.7 .96 5.96 .97 -.64 .11 NS 
Hba1c 6.5    .98    X  X  X  X  NS 
SBP (mmHg) 134.7  13.4 131.7 10.9 -7.63 13.63 NS 
DBP (mmHg) 76.7 5.85 71.5 5.19 1.27 9.22 P<0.025 
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4.8a Mean intake of positive marker and negative foods (paired t test data) 
An overall score was calculated from a list of positive and negative marker foods. Altogether 
there are 30 negative marker foods and 23 positive marker foods, ticking one food item from 
the negative or positive marker food list equates to a score of 1. Mean intake of positive 
marker and negative marker foods are shown in table 4.8a below.  
 
Both sexes significantly reduced intake of negative marker foods (pre programme mean 3.5) 
after a twelve week period (post programme mean 2.02) by more than one negative marker 
P=<0.000 indicating a better choice of foods post programme. There appeared to be no 
significant change between positive marker foods and duration of programme (chart 4.8b).  
 
Charts 4.8b/c summarise positive and negative marker food score pre and post weight 
management programme with 95% CI.   
Table 4.8a: Mean intake of positive and negative marker foods. 
 
Marker  
1
st
 week of programme  12  week of programme   P value  
 n= n= 95% CI  
 Mean  SD Mean  SD    
Positive 
marker foods 
(n=20) 
5.36 3.21 4.96 4.48 -.88 1.68 P=.539 
Negative 
marker foods 
(n=23) 
3.51 2.65 2.02 2.64 .60 2.37 P=0.001 
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Chart 4.8b Positive Marker Food                 Chart 4.8c Negative Marker  
 
4.9 Reported intake pattern for male and female patients  
Charts 4.9a and 4.9b indicate more than three quarters of males and females ate three meals 
on a regular basis before and after completion of the weight management programme. There 
was a higher proportion of patients who reported they ate at breakfast time after the group 
programme (chi
2
= 4.09, df=1, P<0.043). Reported breakfast intake in females increased by 
23% at twelve weeks post programme, with lunch (8.3%) and evening meal consumption 
increasing by (12.9%).  The increase in males was less than females who reported a 12% 
increase in lunch time eating after the programme.  
 
Chart 4.9a                                                      Chart 4.9b                                                      
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4.10 Intake of selected foods pre and post weight management programme 
 
The following reports the proportion of patients who claimed to have eaten a food item in the 
previous 24 hours. The proportion of adults eating a high fibre breakfast cereal or wholegrain 
bread was markedly higher after the programme finished P=0.028. A significant value was 
observed for intake of salad vegetables P=0.021, thus more patients were eating high fibre 
breakfast cereal and salad vegetables post programme (chart 4.11). As summarised in charts 
(appendix 9.3+9.4pp112) fruit, salad vegetables and vegetables consumption increased post 
intervention for both sexes. Consumption of some food items stayed relatively low, though 
this was  
expected due to changes being most apparent in common foods adults eat e.g. reported fish 
intake, low fat cheese and low fat yoghurt were similar to that reported on week 1 of the 
programme which was below 25% of patients.  At twelve weeks, 90% of patients reported 
eating a piece of fruit 24 hours before the questionnaire was administered. 
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4.11 Reported intake of positive marker foods on the previous day for male and female 
patients pre and post intervention 
Chart 4.11a reported intake of positive marker foods for all patients  
 
 
4.12 Negative marker foods 
Four of the 23 negative marker foods were reported as having been eaten less by patients post 
intervention this included butter chi
2
=17.83, df=1, P<0.000, chocolate biscuits chi
2
=7.226, 
df=1, P=.007 and adding sugar to drinks such as tea and coffee chi
2
=22.15,df=1, P<0.000 . 
Reported intake of negative marker foods for males and females can be seen in (appendix 
9.5+9.6pp113). The six most frequent negative marker foods reportedly eaten pre 
intervention for both males and females included plain biscuits, sweets e.g. toffees, sugar 
added to drinks, crisps, adding salt to food and full fat milk. Males reported eating more pre-
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sugared cereals (22.2%), adding more sugar to foods (15.8%) and eating meat pies (15.8) pre 
intervention, this was also the case for post intervention results. Female patients reported 
eating more butter (28.6%), cakes and pastries (17.9%) pre intervention, however reported % 
intakes decreased post intervention particularly for the more common foods such as butter 
and chocolate confectionary. Dietary intake results were not clear for males which, makes the 
interpretation of the data were difficult as no statistical analysis test could be performed for 
both sexes to compare both sexes. Chart (4.12a) indicates the intake of negative marker foods 
was less post intervention.   
Chart 4.12a Reported intake of negative marker foods on the previous day for all 
patients  
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4.13 Changes in self esteem (Rosenberg questionnaire) 
 The first self esteem questionnaire was completed by 32 patients, comparisons between self 
esteem statements pre and post programme were made using chi square tests (only significant 
data is presented ) whilst differences between mean self worth scores were evaluated using 
paired t test (two tailed).  
 
 
4.13a Self esteem score (paired t test data) 
Self esteem was calculated from the responses for the ten self worth statements, in the 
Rosenberg questionnaire. The possible scores ranged from 0-30. Scores between 15 and 30 
are within normal range; scores below 15 suggest low self-esteem.  Mean scores over the 
course of the 12 week programme were similar to the post programme scores (mean 19.76 
S.D. 3.64).  No significant results were observed when comparing mean self esteem scores 
pre and post intervention (P=>0.05).  
Although no significant results were observed, fewer patients fell into the „low self esteem 
category post twelve weeks as indicated in chart 4.13c.  
4.13b      Self esteem week 1                                 4.13c    Self esteem week 2 
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4.13d Self Esteem statements 
On completion of the programme fewer patients agreed with the statement „I wish I could 
have more respect for myself‟ (chi2 = 14.07, df =6, P<0.029), similarly more patients 
disagreed with the statement „feel that I am a failure‟ after twelve weeks (chi2 = 14.97, df= 6, 
P=<0.020), conversely fewer patients said they take a positive attitude chi
2
 = 14.79, df = 4, 
P=<0.005. For the remainder statements no significant results were applicable however, table 
4.13e, indicated 75.8% of patients said they were „satisfied with myself‟, less patients agreed 
with the statement „at times no good‟. A large proportion of patients agreed with the 
statements „I have good qualities‟, do things well and a „person of worth‟ post twelve weeks. 
The statements including „not much to be proud off, feel useless and feel that I am a failure 
stayed relatively low pre and post programme.  
 
Chart 4.13e    Reported % of patients who agree with self esteem statements pre and 
post specialist weight management programme 
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4.14 Quality of life  
The EQ5D (Euroqol, 2010) assessed health related quality of life by asking the patient to 
consider their overall health using five dimensions. Data were available for 33 patient‟s pre 
and post intervention. The chart below includes patients who reported „any problems‟ with 
the five dimensions before and after the specialist weight management programme.   
 
Chart 4.14a Self reported health status profile at week 1 and week 12 
 
 
A Change in EQ5D profile for patients reporting improvement 4 dimensions post programme 
is apparent. The percentage of patients reporting some or extreme problems is lower in 4 out 
of the five domains at three months.  
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4.14b Mean self rated health status pre and post programme 
The results of the EQ5D visual analogue (EQVAS) scores are presented as a mean score for 
all patients. Mean scores pre and post programme were compared using a paired t test. To 
provide a context for these results, mean scores pre programme were compared with scores 
post programme. Obese patients reported a low mean score of 44.83 (S.D. 34.26 )  pre 
programme, which falls below the normal values of similar aged groups in the UK (55-64, 
score 80). At three months mean scores increased considerably to 70.37, (S.D. 15.86) 
P=<0.001 (95%CI – 39.96-14.1).  
 
 
Chart 4.14c  Health related quality of life score pre and post programme 
 
 
 
 
 
 
 
                             SD- Standard Deviation; 95% CI confidence interval  
 
 
Mean 
Health 
status 
score 
Health status 
number week 1 
Health status 
number week 12 
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Chaper 5: Discussion  
The specialist weight management programme has been shown to be an effective service 
model in a community NHS setting and continues to be offered to patients referred by their 
GP for dietetic advice on weight management despite no extra funding.  The aim of the 
evaluation was to analyze and evaluate these findings, sharing lessons of best practice to 
improve the service offered to patients with a BMI > 30.  
The evaluation had three main objectives.  
To compare clinical outcomes including body weight, BMI, lipids, fasting blood glucose, 
Hba1c and blood pressure pre and post 12 weeks of the weight management group 
programme.  
1) To evaluate reported food intake, self esteem and quality of life pre and post 12 weeks 
of a weight management group programme 
2) To identify patients who opted for one to one dietetic intervention and compare 
findings to group programme patients.  
 
5.1 Aims of obesity treatment  
“To devise and deliver dietetic weight management care, based on current evidence and best 
practice, which helps the individual to make and maintain positive lifestyle changes that are 
best suited to their particular needs and expectations”  (DOM, 2007).  The specialist weight 
management programme, run by the Liverpool community dietitians and community food-
workers reflects the aims of obesity treatment within a community health setting. Before the 
specialist service was introduced, obese patients were given one route of care which included 
one to one appointments with a dietitian.  In 2009 patients were given the choice to attend 
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one to one sessions with a dietitian, a 12 week group programme or both. The group 
programme was developed using best evidence available in order to facilitate 5-10% weight 
loss, change patient eating and exercise behaviours with the expectation of clinical 
improvement in co-morbid conditions. Uptake of the group programme is deemed to be the 
most popular choice for patients and has provided a strong element of support from staff and 
patients. Whilst discussion will relate to the first 3 months of the programme, monitoring of 
patients will continue for two years.  
5.2 Changes in weight and BMI 
The success of treatment is affected as much by structure as by the principles and techniques 
used within it (Foreyt et al. 1981). For many weight management methods there are few 
scientific studies evaluating their effectiveness and much of this data is from long term 
studies outside the UK, so these results may not be generally applicable to community 
clinical practice (NOO, 2009). In spite of the limitations of the present evaluation, and the 
absence of a control group, treatment effectiveness was shown to be significant. Mean weight 
reduction at three months was approximately 1.9 kg (95% CI 1.12- 2.86). Though overall 
weight loss at three months can be improved, a sustained reduction in body weight was the 
main goal during the programme, not the greatest weight loss in a short time. Rapid weight 
loss is associated with reduced muscle mass, preservation of muscle mass is particularly 
important for maintenance of skeletal muscle (Berg, 2002) in obese patients.  
Significant differences in weight and BMI were observed between men and women which 
suggests the programme is suitable for both sexes in a similar community based weight 
management setting, however analysis of the data indicated male patients finished the 
treatment most satisfactorily with mean weight loss (-3.9kg) markedly higher than females (-
1.4kg) post programme P<0.001).  One reason for this weight difference may be due to 
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female‟s dieting more frequently than men, successful weight loss is not easy thus such 
setbacks and periods of weight plateau  may deflect the patient from the original goal 
(Drewnowski & Yee, 1987). Other studies consider that even though men are less 
predisposed to start weight reduction treatments they are more conscientious in their 
approach once they have embarked on them (Rossner, 1989). These results could be 
explained either because there was a higher female to male ratio in group sessions or because 
it may be easier to change the eating habits of male patients.  
 Attrition and non attendance at clinics is a common problem in weight management, 
furthermore rates of attrition are not comparable among different weight management 
programmes because they are defined differently from one treatment to another. Despite this, 
treatment approaches have tried to consider reasons why patients drop out. Honas, Early, 
Frederickson and  O Brien (2003) conducted a large clinical based weight loss programe  
measuring predictors of attrition. Significant risk for dropout, measured as bivariate relative 
risk (95% confidence interval) was found among patients who were: females, divorced and; 
age < 40. In the present evaluation 18%  of patients who started the programme dropped out  
before completing at twelve weeks, which is similar to Liverpool community health 
department figures for other programmes (10-20%). Explanations given by patients to their 
dietitian for not attending group sessions included ill health, holidays, time and attending 
other slimming groups.  
The attrition rate was considered accetable during the evaluation period, which was compared 
to other DNA  rates within the dieteic service.  Mean BMI (35) at twelve weeks was  also 
significantly lower 0.66kg/m2 (95% CI, 0.21-1.10), a 1.7% reduction when compared with 
pre intervention results.  
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5.3 Weight maintanence  
Weight loss is difficult to achieve and maintaining weight loss is an even greater challenge, 
thus a mean % reduction in body weight of male (3.4%) and females (1.5%) patients at three 
months who lost weight, demonstrated the programme is successful in the short term and 
aims to compare favourably with other dietary programmes shown to be effective in the 
treatment of obesity.  During the evaluation period five patients stabilized their weight and 
two patients regained weight. It would be interesting to follow up such patients at six months 
to investigate factors which may promote weight gain. Identifying factors associated with 
weight loss maintenance can enhance understanding of the behaviours and prerequisites that 
are crucial in sustaining a lowered body weight. One study by Elfhag and Rossner (2005) 
described factors that may act as moderators and mediators in promoting weight maintenance 
or act as obstacles for long term success. Weight regain is associated with a number of factors 
including sedentary behaviours and a history of weight cycling, some of which can be related 
to patients in clinical practice. A cautionary approach should be taken with such explanations 
for weight loss as the majority of studies were based on behaviour modification treatment‟s 
or individual dieting efforts in samples mainly consisting of women.  
                                                                                                                                                                        
5.4 Weight Loss and activity 
Although patients trying to lose weight should increase their physical activity to 60 minutes 
per day over five days (NICE, 2006), a  meta-analysis review reported „physical activity does 
not appear to contribute significantly to weight loss, however it is critical for maintenance of 
weight loss. In this evaluation, data on physical activity was not collected due to time and 
ethical review. However a key factor for motivating patients to help increase activity level, 
was the incentive of a free pedometer which was provided to patients at the start of the 
76 
 
programme. The use of the pedometer created group discussion  on steps per day. A review 
by  Bravata, et al. (2007)  found pedometer usage was dependant on age, users were more 
likely to be aged 59 years or above. Interestingly mean age of patients in the present 
evaluation was also 59 years. Other reasons for patients increasing physical activity included 
taking their dog for a walk on a regular basis, gardening and line dancing. The NOO (2009) 
reports such activity as mentioned is rewarding, realistic and achievable.    
 
5.5 Comparing evaluation results to counterweight programme 
 One well designed weight management programme in primary care is the counterweight 
model.  Patients who completed the counterweight programme were more likely to achieve a 
greater weight loss (3.4kg at 3 months) and more likely to achieve a significant weight loss of 
5% or more when compared to non compliant patients. The counterweight team also 
emphasised „It has to be recognised that not all patients are appropriate for intensive 
management and more rigorous patient screening using the stages of change model may 
improve patient selection at time of referral (Counterweight, 2004).  
In the present evaluation patients were referred by their G.P and suitability for treatment 
screened by a Dietitian before treatment commenced to ensure patients were motivated to 
change. Overall weight loss and BMI change was significant but less than counterweight at 
three months, however the results from the evaluation show a positive outcome, taking into 
account this is a new service being offered. Some of the differences between counterweight 
and the specialist programme are outlined in table 5.5a.  
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Table 5.5a: Differences between the specialist programme in Liverpool 
compared to Counterweight. 
 Step by step Counterweight 
Number of appointments 12 6 
 Duration with patient 2 hours (group setting) 1 hour 
 Goal Setting Similar to counterweight, 
included 4 practical cooking 
sessions 
Exclusive Goal Setting 
 
Despite the good level of awareness amongst patients in this evaluation to reduce body 
weight for health reasons, studies have reported subjects are not aware of  the benefits a 5-
10% loss of initial body weight (NICE, 2006) or why this is expected by their practitioner at 
least 6 months post treatment. In the present evaluation the number of individuals who lost 
5% of their body weight was initially low (5.7%) post programme.  At this stage in the 
evaluation such weight loss was not considered problematic , due to the short time scale, one 
aim was to support patients to go onto achieve long term sustainable weight loss over time. If 
weight loss was not achieved or patients had only maintained their weight at 3 months other 
options for treatment were discussed, with their Dietitian and further support offered.  
5.6 Improving cardiovascular and metabolic risk 
 It is clear that significant health benefits result from a modest weight loss of 5-10% (NICE, 
2006), particularly for groups of patients with impaired glucose tolerance (Wilding, 2006). A 
maintained weight loss of -5% is associated with substantial intrabdominal fat loss and 
significant prevention or amelioration of comorbidties particularly cardiovascular and 
metabolic risks  (Counterweight, 2008). This is important as half of all patients (50%) who 
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were refered by their G.P for specialist support to the Liverpool weight management 
programme had at least one obesity related comorbidity pre intervention. This is concerning 
as most comorbidities known to be exacerbated by obesity are potentially preventable. 
5.7 Clinical Biochemistry  
The recording of individual biochemical data  for the present evaluation was difficult due to 
extracting information from patient medical notes. Furthermore clinical biochemistry 
measures were only available if a practioner had requested bloods to be taken which may 
have underestimated the number of patients with dyslipidemia, elevated blood glucose and 
hypertension during the evaluation period. Severe obesity (BMI>35) was apparent in more 
than two thirds (66%) of the patients pre intervention which reflects the high prevelance of 
obesity related disease.  
5.8 Cholesterol  
Obesity can coexists with a variety of cardiovascular risk factors and has been related to 
greater cardiovacsular risk in a variety of observational studies. The risk of heart disease is 
doubled in patients with a BMI>25kg/m2 however it is the proportion of LDL cholesterol to 
HDL cholesterol which influences the degree to which atheroscelerosis is likely to develop 
(Calle, Thun, Petrelli, Rodriguez, & Heath, 1999). 
In the present evaluation different relationships were observed between obesity and 
hypercholesterolemia. Firstly, mean mean total cholesterol levels of 4.7 mmol/l or above 
were common pre intervention. This finding was ideally below the population average of 
5.7mmol/l however males and females presented different lipid profiles pre intervention. 
Mean LDL fractions were elevated in females (>3.17mmol/l) while mean TG were elevated 
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in males (>2mmol/l). High density lipoprotein cholesterol levels did not change over the 3 
month time frame.  
During the follow up period  a small reduction, in total cholesterol was observed post 
programme however this was not signficant (P>0.05) and other lipid parameters were similar 
to pre interventions values.  
 More robustly a systematic review of thirteen studies between 1966 and 2001 with a follow 
up of two years reported cholesterol had a significant positive linear relationship with weight 
change, where change in weight explains about 80% of the cholesterol difference variation 
(Adj R
2
 = 0.80). For every 10 kg weight loss a drop of 0.23 mmol L
−1
 in cholesterol may be 
expected for a person suffering from obesity (Poobalan et al. 2004). The findings in the 
present programme are weaker in terms of changes in lipid fractions however a variety of 
issues should be considered. Firstly, a larger sample size and 6 month data would be required 
to confirm and compare to pre intervention results. In addition, a major limitation to the 
present evaluation was that information such as statin medication or saturated fat intake was 
not recorded.  
  
5.9 Fasting Blood Glucose Level and HbA1c  
Obesity is associated with an increased risk of developing insulin resistance and type 2 
diabetes. In obese individuals, adipose tissue releases increased amounts of non-esterified 
fatty acids, glycerol, hormones, pro-inflammatory cytokines and other factors that are 
involved in the development of insulin resistance. When insulin resistance is accompanied by 
dysfunction of the pancreatic islet β-cells, insulin fails to control blood glucose levels (Kahn, 
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Hull, & Utzschneider, 2006). Abnormalities in β-cell function are therefore critical in 
defining the risk and development of type 2 diabetes.  
From this analysis, 7 patients who entered the programme suffered pre-existing diabetes. 
Unfortunately, measurements for HbA1C were not available for the course of this evaluation. 
Therefore fasting blood glucose was used as determinant for newly diagnosed diabetic 
patients during the evaluation. On referral, mean fasting blood glucose was 5.7mmol/l 
(values, 4.1-7.3), this was within the impaired glucose tolerance range (5.6-7mmol/l). Similar 
results were found post programme (5.9mmol/l). These results were not significant however 
the findings reflect the relatively small sample of patients and weight loss achieved especially 
in women. This also suggests diabetic patients would benefit further by decreasing,  5% -10% 
of their total body weight before any changes in fasting blood glucose were observed.  This 
observation is consistent with lifestyle interventions which have found risk factors to be 
decreased in subjects who have lost the most weight post intervention with initial impaired 
glucose tolerance, type 2 diabetes, or hypertension. This is because changes in risk factors are 
more likely in subjects with abnormal baseline levels (Douketis, Feightner, Attia, & Feldman, 
1999).  A limitation to such findings is that many programmes are usually intervention 
specific and concentrate solely on reducing the risk of one comorbidity, rather than focusing 
on weight loss as an overall reduction in risk factors.  
 
5.10 Blood Pressure  
In epidemiological surveys, thresholds of 140 mmHg (systolic) and 90 mmHg (diastolic) are 
often used when measuring the proportion of the population with hypertension (DOH, 2008). 
Any particular threshold used to classify blood pressure as high or low is, to some extent, 
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arbitrary, as any increase in blood pressure is associated with an increase in risk of 
cardiovascular disease (Williams, Poulter, & Brown, 2004).  
 
On referral to the weight management programme, mean systolic blood pressure was 
140mmhg for males classified as grade 1 (mild hypertension) and 131.8 mmhg (high normal) 
for females. When comparing the data available at twelve weeks, mean systolic blood 
pressure results pre intervention 134.7 (+ 13.4 S.D) was lowered post intervention (131.7 + 
10.9 S.D) but not significantly different (P =.435) Also several patients were diagnosed with 
diabetes prior to the evaluation hence optimal B.P goals are lower for diabetic patients SBP 
<130mmhg and DBP <80mmhg. However positive significant results were found between 
diastolic blood pressure pre (76.7+ 5.85) - and post intervention (71.5+5.19) which, may 
indicate obesity in this group of patients is highly related to the risk of hypertension in both 
men and women. This improvement in blood pressure was an interesting finding considering 
the majority of patients had not lost 5-10% of total body weight. Other factors especially 
excessive alcohol consumption have been shown to increase the risk of hypertension, 
however the population impact is smaller because the prevalence of those factors is lower 
(Wallace et al. 1981). Secondly greater intake of sodium and lower consumption of calcium 
have also been linked to the occurrence of hypertension (Sacks, Svetky, & Vollmer, 2001) 
but this dietary information was not collected during the evaluation period. Advice on 
decreasing salt intake did form a part of the group programme and 1-1 as part of the health 
education for weight management. 
 
Previous large cohort studies have shown that a variety of factors, including relative weight, 
heart rate, alcohol intake and levels of blood glucose, serum protein, triglyceride are related 
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to hypertension occurrence in one or both sexes, though excess adiposity is one of the most 
controllable factors (Garrison, Kannel, Stokes, & Castelli, 1987).  
Furthermore one major limitation to the evaluation is that throughout the three month period 
a patient may have been placed on hypertensive pharmacological treatment which may have 
affected post intervention results. 
 
5.11 Reported food choice  
 
The evaluation compared choice of food not nutrient intakes. Using foods rather than 
nutrients to represent data has advantages when evaluating dietary intervention in patients. 
This is because dietary advice has to be in given in terms of foods, it is also logical to assess 
the diet in the same way. The methods used in this evaluation primarily compared food data 
pre and post weight management programme. A gold standard method for measuring dietary 
intake in randomised control trials includes the doubly labelled water method, however 
validated questionniares such as the FIQ  (Johnson et al. 1999) have the potential to collect 
important information quickly at a lower cost. Previous studies have demonstrated, using 
food intake questionniares with large samples can minimize errors and improve reliability for 
dietary analysis  (Johnson et al. 1999).  
 
The weight management group programme included a session on the importance of breakfast 
consumption and included advice on suitable portion sizes of healthier cereals. The results 
showed that the proportions of patients who reported they ate breakfast after the group 
programme had significantly increased (P<0.043) when compared to the pre group numbers. 
100% of female patients reported eating breakfast post programme compared to 62% of 
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males. The percentage of male patients reporting to eat three main meals a day was also 
lower than females. This observation is in agreement with other studies shows a link between 
obesity and skipping meals, or an inconsistent meal pattern may mean skipping meals to 
reduce
 
calories. Analyses of behavioural data in men and women suggests eating breakfast is 
associated with reduced dietary fat  intake and can minimizes impulsive snacking in weight 
reduction programmes (Elfhag & Rossner, 2005) . One cross sectional  study (Huang, Fan, 
Liao, Tsai, & Hu, 2010) investigated the association between frequency of breakfast 
consumption and prevalence of obesity. The study revealed that the prevalence rate of obesity 
decreased as the frequency of breakfast consumption increased.  
The present findings show that patients reported  eating less negative marker foods post 
programme (P= 0.001) which suggests that they were making healthier food choices. 
Negative marker foods include foods high in saturated fat, salt and sugar, and are described in 
the weight management programme as foods to eat less of. There appeared to be little  change 
or increase in positive marker foods post programme possibly indicating patients are already 
eating these foods but in larger portion quantities. Looking at individual foods the majority of 
positive marker foods increased post intervention; though this data was not significant. In 
particular, wholegrain bread, other starchy carbohydrate foods, fruits and vegetables 
increased post programme which is a positive finding. A higher percentage of patients 
consumed a piece of fruit or vegetable post intervervention this is a positive finding and 
possibly indicates patients are more aware of the importance of fruits and vegetables.  
 
The percentage of patients eating foods such as butter and chocolate decreased post 
intervention,  indicating patients were more aware of the association between these foods and 
increased risk of weight gain or cardiovascular risk. However interpreting dietary data in 
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terms of percentage points is extremely difficult because further data collection is needed to 
improve the reliability of such results. Although  it maybe suggested that reported behaviour 
(as opposed to actual behaviour)  has changed or that the patients have taken on board the 
advice given in the group.  
Despite government recommendations to reduce saturated fat intake, trends were also 
identified with particular foods and drinks, one example of this was type of milk. Patients 
tended to report drinking full fat milk pre intervention instead of semi skimmed milk or 1% 
milk. The percentage of patients drinking full fat milk post weight management advice 
decreased, although this data was not signficant. A larger sample size at six months may 
indicate  patients are becoming more aware of the total fat content and that calcium intake 
will not be reduced by changing to semi skimmed/skimmed milk.  
 
5.12 Health Related Quality of Life  
This evaluation considered the impact of obesity on health related quality of life as defined 
by the dimensions of the EQ5D (Euroqol, 2010) and compared VAS scores in patients who 
attended pre and post weight management sessions. The majority of patients rated pain and 
discomfort as the most reported problem. In a cross sectional study by Hitt et al. (2007), 
results suggested that obese adults were more likely to experience pain, when compared to 
healthy weight individuals.  The present results indicated the percentage of patients reporting 
some or extreme problems is lower in 4 out of the five domains post intervention. In 
comparison to other studies similar proportions (>60%) of respondents with high risk for 
diabetes reported experiencing some pain or discomfort.  
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Patients rated their own health status (VAS scores) higher than at pre evaluation which 
resulted in a significant result. Patients‟ own health score has significantly increased 
(P<0.001) since attending the twelve week programme and confirms the importance of how 
patients perceive health post weight management advice.  It is unclear in the present 
evaluation why current health status was improved so quickly in patients after three months 
compared to the start of the programme, because a number of factors may have contributed to 
this increased feeling of well being including weight loss, dietary change, decrease in energy 
intake and social support.  
 In one study, several limitations were found when interpreting the results of patients and 
health related quality of life using the EQ5D (Euroqol, 2010). The present evaluation does 
not take into account patients who were antidepressant which may influence patients score 
rating. Secondly it is likely that the health state of obese patients with depression, in addition 
to a chronic medical disease would be significantly reduced.  
 
5.13 Self esteem  
Obesity is associated with alterations in psychosocial health. In addition to eating behaviour 
and quality of life, a UK study found nearly half of obese patients had anxiety and depressive 
disorders (Tuthill, Slawik, Rahilly O, & Finer, 2006). Individuals with low self esteem are 
often more vulnerable to depressed feelings, anxious thoughts and increased health problems.  
 
One of the aims of this evaluation was to examine changes in patient self esteem pre and post 
programme. It was predicted that self esteem would improve as a result of the programme.  
Although it was hypothesized that there would be changes in levels of self esteem, the 
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average scores for all patients fell within the normal levels (scores of 15-30). This finding 
was consistent across the sexes. Other studies investigating the relationship between weight 
and psychopathology are inconsistent. Furthermore some items are interpreted differently 
within studies reducing the possibility of comparing the results found in the evaluation to 
previous studies evaluating weight management outcomes.  
The present results suggest the 12 week programme did not worsen self esteem and did not 
increase vulnerability which is a positive finding.  Wardle et al. (2006) stated that regardless 
of gender, socio-economic status or ethnicity, reports of depressive symptoms were not 
significantly higher in obese individuals when compared to normal weight groups (Wardle et 
al. 2006). In some clinical populations, patients with comorbidities reported a higher number 
of depressive symptoms. In the present evaluation, obesity was not associated with low self 
esteem however some patients scores fell below the threshold (<15) before group sessions 
commenced,  suggesting that  self esteem may be related with body satisfaction than actual 
weight and BMI status, however further research is needed to prove such results.   
The RSES was a simple tool to administer and evaluate patient self esteem, however some of 
the questions were left unanswered. It was clear patients felt quite sensitive about some of the 
questions being asked in the rosenburg. Two patients stated next to question five „I have 
plenty to be proud about!‟ and question eight „I have always had respect for myself, silly 
question!‟ 
  
 
 
 
87 
 
5.14 Conclusion  
It has been established that patients attending a 12 week weight management programme run 
by community dietitians and foodworkers:  
 
  Achieved clinically beneficial reductions in weight and BMI when compared to to 
week one of the evaluation 
 Showed improvements in food choice were reported: particularly decreases in 
negative marker foods at week twelve of the programme. 
 Improved HRQL scores were greatly improved when compared to week one of the  
programme 
 
 
5.15 Limitations 
5.15a Comparing group session results to one to one care 
 Unfortunately at the time of this evaluation comparing group sessions to one to one 
dietetic care was not possible due to time and caseload. 
 The use of a control group would have provided exact quantification of the 
programmes full potential and achievement in relation to weight, weight loss and BMI 
change, though this was not an option due to ethical consideration. 
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5.15b Six Month Data  
 The benefits of this programme on other clinical outcomes  and self esteem need 
further investigation.  
 Six month data would be needed to prove whether the programme is effective in the 
long term and whether improvements are sustained.   
 The evaluation will continue at subsequent follow up stages. The next evaluation will 
focus on patients post six months weight management advice.  
 
5.16 Implications for future research and intervention  
This evaluation has contributed to the evidence base and revealed a number of advantages to 
patients who attend a 12 week group programme. Whilst this evaluation has used the most up 
to date evidence, there is room for improvement. Where improvements are needed future 
recommendations for the service and evaluation are outlined below.  
5.16a Factors associated with recruitment 
 Determination of patients „readiness‟ for lifestyle changes should be carried out prior 
to enrolling them into the programme. Where lack of readiness is found, patients 
should be referred back to their GP before embarking on the programme 
 
5.16b Increasing physical activity  
 Most dietary interventions combined with exercise sessions e.g. gym lessons results in 
greater outcome and long term weight maintenance.  
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 Low to moderate intensity exercise class run by a instructor  who will increase the 
confidence of the participants at initial consultation and most importantly how to 
enjoy exercise (incorporate FITT approach including type of activity, frequency, time 
and intensity)  
 Development of coping strategies when faced with situations that would reduce 
adherence to exercise and evaluation of this. 
 
5.16c Successful weight maintenance  
 Follow up of those patients at six months of those who have achieved weight loss will 
enable them to maintain  their weight loss  
5.16d Difficulties encountered in evaluating the service  
Problems were encountered with access to or missing post intervention clinical data.  
Therfore it is vital patients referred with blood results are followed up post intervention in 
a timely manner. 
* Difficulties were encountered when processing questionniare data, which resulted in 
data  being  inputted by hand.This process  needs suitably trained and motivated staff to 
do this accurately. 
 * A standardised computerised database should be developed for patients attending 
weight management groups or one to one to care and used locally to facilitate patient 
monitoring and audit. 
* Cost of the group sessions in comparison to one to one dietetic care was not conducted 
in this evaluation however this will be considered  for future service evaluation.  
 
TOTAL WORD COUNT = 16, 632 
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Date:  _______________   ID Code: __________________ 
                (For office use only) 
 
Department of Community Nutrition 
and Dietetics  
 
Food Intake Questionnaire  
Adult 1    
  
 
The questions ask about the foods you ate YESTERDAY. For each question 
please tick the YES box if you ate the food yesterday. If you did not eat the 
food yesterday tick the NO box. All of the information you give will be treated 
in confidence and not used by any third party.  
 
About yourself: 
Name  
Are you:  Male [   ] Female [   ] 
 
Date of Birth    _______________________________ 
 
What is your postcode? )____________________________ 
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What did YOU eat and drink yesterday? 
                                Yes
 Yesterday, did you:      
 Eat at breakfast                     [  ]   
 Eat at Lunchtime        [  ]   
 Eat an evening meal                    [  ]   
 Do any physical exercise e.g.  walking, jogging, cycling                [  ]   
 
Did you at any time yesterday eat any amount of any of the following: 
 
Breakfast cereals:                    
Branflakes, Shredded wheat, Weetabix, Allbran, Fruit 'n' fibre?                [  ]   
Rice Krispies or Cornflakes?        [  ]   
Frosties or Sugar Puffs, Ricicles, Coco Pops?                    [  ]   
Bread: 
White bread (slices or buns)?        [  ]   
Brown or wholemeal bread any type (slices or buns)?                 [  ]   
Butter or margarine  
Butter:           [  ]   
Hard margarine: e.g. Stork, Echo?       [  ]   
Ordinary soft margarine: e.g. Blue Band, Summer County?    [  ]  
Polyunsaturated spread: e.g. Vitalite or Flora?                  [  ]   
Low fat spread: e.g. Outline, Gold, Freeway, Hi-life or Delight?                 [  ]   
Other spreads e.g. Benecol, ProActive?                    [  ]  
Biscuits: 
Plain biscuits e.g. malted milk, Digestives, Rich Tea etc?                  [  ]   
Any Biscuits which were covered all over in chocolate:  
e.g.  Kit-Kat, Penguin?                      [  ]   
Cakes and puddings: 
Swiss roll (plain or chocolate), doughnuts,  scones, individual pies,  
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jam tarts, custard tarts etc?        [  ]   
Fruit pie, sponge pudding, tinned fruit, jelly, trifle,  lemon meringue,  
cheesecake, milk pudding like rice, semolina,  tapioca, custard etc?   [  ]   
Sweets & chocolates: 
Boiled sweets, fruit gums or pastilles, liquorice, jelly sweets, chews,  
toffees, chewing gum etc?        [  ]   
Chocolates or chocolate bars like: Mars Bar, Twix, Quality Street,?   [  ]   
Ice cream, choc-ices, ice lollies, ice-pops?      [  ]   
 
Did you at any time yesterday eat any amount of any of the following: 
Sugar:          Yes 
Sugar (white or brown) in any drink such as tea, coffee, cocoa etc   [  ]   
Sugar (white or brown) on any food such as cornflakes or pancakes?               [  ]   
 An artificial sweetener (like saccharin, sweetex, canderel etc)?                [  ]   
Starchy Foods                     
Boiled potatoes?         [  ]   
Mashed potatoes?         [  ]   
Baked or jacket potatoes?        [  ]   
Roast potatoes?                      [  ]   
Chips?           [  ]  
Crisps (any type or flavour)?        [  ]   
Fruit: 
Any fresh fruit such as apples, oranges, pears, bananas, plums etc?   [  ]   
Vegetables and Salad: 
Any other vegetables e.g. peas, cabbage, carrots, leeks, green beans,  
parsnips, tinned tomatoes, cauliflower, leeks, turnips or sprouts etc?                [  ]   
Any fried vegetables e.g.  Fried onions, mushrooms or tomatoes etc?                [  ]   
Any type of salad such as:  celery, tomatoes, lettuce, cucumber,  etc?                [  ]   
 
Beans, Peas and pulses: 
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Baked beans?          [  ]   
Tinned Peas?          [  ]  
Other pulses e.g. lentils, chick peas, kidney beans?     [  ]  
Meat: 
Steak?           [  ]  
Tinned meat e.g. corned beef, luncheon meat, tinned ham?    [  ] 
Chicken           [  ]    
Ordinary burger?         [  ]   
Ordinary sausages?         [  ]   
Low fat burger?                      [  ]   
Low fat sausages?         [  ]   
Meat pie, Cornish pasty or sausage roll etc?      [  ]   
Minced meat?          [  ]   
Did you at any time yesterday eat any amount of any of the following: 
Yes: 
Fish fried in batter?         [  ]   
Fish cooked in other ways e.g. boiled, steamed, grilled?                 [  ]  
Oily fish e.g.  sardines, mackerel, , pilchards, fresh tuna?                 [  ]  
Cheese:           
Cheese e.g. Cheddar, Leicester, Cheshire?      [  ]  
Soft cheese e.g. Philadelphia, Dairy Lea?      [  ]   
Low fat cheese e.g. Shape or Philidelphia lite?                  [  ]  
Yoghurt: 
Full fat yoghurt?         [  ]  
Low fat  or diet yoghurt?        [  ] 
Other types of yogurt e.g. ProActive, Benecol?                   [  ]  
Take-away food:          
Fish and chips?                      [  ]   
Pizza?           [  ]  
Curries?          [  ]  
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Chinese?          [  ]  
Kebabs?          [  ]  
Salt: 
Did you put any salt on your food?       [  ]   
Did you at any time yesterday drink  any amount of the following: 
Fizzy drinks 
Regular or ordinary fizzy drink? (e.g. Coca-Cola, Pepsi, Fanta)                [  ]   
Diet or low calorie sort of fizzy drink?(Diet Coke, Pepsi Max etc)   [  ]   
Still cordials (e.g.  Orange squash, Ribena, barley water etc) 
Diet or low calorie sort of still drink?       [  ]   
Regular or ordinary still drink?                    [  ]   
Milk (in tea, coffee, milkshakes,  cocoa or on cereals) 
Ordinary full fat milk?                     [  ]   
Semi-skimmed or skimmed milk?       [  ]   
Alcohol 
Beer,lager or cider?         [  ]   
Wine           [  ]   
Sprits Sherry, Port Martini        [  ]   
such as whisky, vodka, gin    
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Self-Esteem  
 
What to do:  
Below is a list of statements dealing with your general feelings about yourself. If you strongly agree, 
circle SA. If you agree with the statement, circle A.  If you disagree, circle D.  If you strongly disagree, 
circle SD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. On the whole, I am satisfied with myself. SA A D SD 
2.* At times, I think I am no good at all. SA A D SD 
3. I feel that I have a number of good qualities. SA A D SD 
4. I am able to do things as well as most other people. SA A D SD 
5.* I feel I do not have much to be proud of. SA A D SD 
6.* I certainly feel useless at times. SA A D SD 
7. I feel that I‟m a person of worth, at least on an equal plane 
with others. 
SA A D SD 
8.* I wish I could have more respect for myself. SA A D SD 
9.* All in all, I am inclined to feel that I am a failure. SA A D SD 
10. I take a positive attitude toward myself. SA A D SD 
Appendix 7.2 
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Health Questionnaire 
 
English version for the UK 
(validated for Ireland) 
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By placing a tick in one box in each group below, please indicate which statements best 
describe your own health state today. 
 
Mobility 
I have no problems in walking about  
I have some problems in walking about  
I am confined to bed  
 
Self-Care 
I have no problems with self-care  
I have some problems washing or dressing myself  
I am unable to wash or dress myself  
 
Usual Activities (e.g. work, study, housework, family or 
leisure activities) 
I have no problems with performing my usual activities  
I have some problems with performing my usual activities  
I am unable to perform my usual activities  
 
Pain/Discomfort 
I have no pain or discomfort  
I have moderate pain or discomfort  
I have extreme pain or discomfort  
 
Anxiety/Depression 
I am not anxious or depressed  
I am moderately anxious or depressed  
I am extremely anxious or depressed 
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To help people say how good or bad a health 
state is, we have drawn a scale (rather like a 
thermometer) on which the best state you can 
imagine is marked 100 and the worst state you 
can imagine is marked 0.  
 
We would like you to indicate on this scale how 
good or bad your own health is today, in your 
opinion. Please do this by drawing a line from 
the box below to whichever point on the scale 
indicates how good or bad your health state is 
today 
Your own 
health state 
today 
9 0 
8 0 
7 0 
6 0 
5 0 
4 0 
3 0 
2 0 
1 0 
100 
   Worst 
    imaginable 
     health state 
0 
Best  
imaginable 
health state 
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Department of community Nutrition 
Grove Street 
Liverpool  L7 7HG 
0151-295-3863 
Participant Information Sheet 
You have been referred to the weight management team, by your doctor for dietary advice 
and an appointment has been arranged for you to see the dietitian.  
The weight management programme supports those who need to lose weight or where 
losing weight may help an existing medical condition such as diabetes. As part of the 
programme you will be offered   an appointment assessment clinic with a senior dietitian.  
You will then be given the option of a treatment option to meet your personal needs.  
The treatment options available include: 
 One to one care with a dietitian  
 Weight management group sessions with the dietitian and  food workers 
 
Service evaluation of a specialist weight management programme 
Your treatment is being assessed for effectiveness and quality and we ask your permission 
to be part of this process. It is therefore important for you to understand why the evaluation 
is being done and what it will involve. Please take time to read the following information. Ask 
the dietitian if there is anything that is not clear or if you would like more information.  
 What is the purpose of this evaluation?  
To review how well the weight management programme is being run and how effective it is 
in supporting you to lose weight and keep the weight off 
It will also assess what impact it has on your medical condition and will assess if attending 
our service has improved your health and lifestyle. The evaluation will monitor how effective 
the treatment you receive is at helping you lose weight and manage any other medical 
problem you may have e.g. raised cholesterol. Measurements such as cholesterol that are 
conducted by your G.P as part of your normal treatment will be included in the data 
collected. To do this will be asked to complete a questionnaire which can be returned to your  
dietitian.  
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Do I have to take part? 
 It is completely your choice to decide whether or not to take part. If you decide that you do 
not want your progress monitored it will not affect your treatment or follow up with the 
dietitian in any way, you can inform us when you complete the consent form attached. 
 What will happen to me if I take part?  
 You will receive an assessment and agree a treatment plan as normal with the 
dietitian. 
 You will be asked about any other medical conditions you have and the medication 
you are currently taking.  
 Your progress monitored to include changes in your weight and any relevant blood 
tests which are done routinely as part of your treatment. 
 The dietitian will record the results of any other tests that have been conducted by 
your G.P. as part of your usual treatment e.g. blood pressure  
 You will be asked to complete a questionnaire to collect information on your diet, 
quality of life and self-esteem, before and after your treatment 
  
What are the possible disadvantages of taking part?  
 Questions of a sensitive nature regarding your medical history will be asked; however such 
questions are routinely asked as part of your usual assessment and treatment with the 
dietitian. If you have any questions please speak to your dietitian. 
 Will my taking part in the evaluation be kept confidential?  
All of the information that is collected will remain strictly confidential. Only your dietitian will 
have access to your medical information.  
 What will happen to the results? 
 The data from everyone who agrees to take part will be analyzed. The results will be written 
up to inform our patients, the service managers and other health professionals of how best 
to develop services in the future. If appropriate they will be submitted for publication in 
relevant journals, to help inform other practitioners on ways to improve practice. You will not 
be identified in any reports or publications.  
 Who is organising and funding this research?  
 The research is funded and organised by Liverpool Primary Care Trust. (Department of 
Community Nutrition) 
 Who may I contact for further information?  
Thank you for taking the time to read this information. If you would like more information 
about the evaluation before you decide whether or not you would be willing to take part 
please contact Dr Brian Johnson (at the address above). 
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Patient identification Number:                                                 Department of Community Nutrition 
Abercromby Health Centre  
Grove Street  
 Liverpool  
L7 7HG 
Tel: 0151-708-9370 
CONSENT FORM 
Title of Project  
 
Name of Researcher  
1. I confirm that I have read and understand the information sheet about the weight management 
evaluation dated………….. for the above study. I have had the opportunity to consider the information 
as questions and have had these answered satisfactorily. 
2. I understand that my participation is voluntarily and that I am free to withdraw at any time without 
giving any reason, without my medical care or legal rights being affected.  
3. I understand that relevant sections of my medical notes and data collected during the study, may 
be looked at by individuals from the NHS trust, where it is relevant to my taking part in this research. I 
give permission for these individuals to have access to my records.  
4. I agree to my GP being informed of my participation in the study.  
5. I agree to take part in the above study. 
Name of patient                            Date                                        Signature 
 
Dietitian                                         Date                                       Signature  
 
When completed: 1 for participant; 1 for researcher site file; 1 (original) to be kept in 
medical notes                                
               
 
Please initial 
box 
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Ethical approval  
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8 Pilot Study  
A pilot study often provides the researcher with ideas, approaches and clues you may not 
have foreseen before conducting the pilot study. Such ideas and clues increase the chances of 
achieving clearer findings in the main study. Furthermore it can greatly reduce the number of 
unanticipated problems because you have an opportunity to redesign parts of the study and 
overcome difficulties that the pilot study reveals (Meriwether, 2000). 
 
8.1 Data collection for pilot study 
 
In line with the evaluation protocol, height, body weight and biochemical data (if available) 
was measured at baseline and follow up. Specific sections were identified to give descriptive 
statistics including food intake, self esteem and quality of life. The first questionnaire (FIQ), 
Rosenburg and EQ5D were completed at week 1 and completed at week 12 (follow up). The 
questionnaires were returned to the dietitian.  
 
8.2 Pilot -Self administration  
 
20 patients who were actively taking part in weight management group programmes run by 
the community dietitians across Liverpool gave consent. The pilot study ensured the 
researcher that wording of questions was easy to follow to prevent ambiguity before the 
evaluation commenced.  
 
 
 
 
109 
 
8.3 Pilot study results 
Response rate was high for completion of FIQ and EQ5D (100%) however only 50% of the 
patients completed the Rosenburg questionnaire (50% of the sample were given the incorrect 
version of the Rosenburg questionnaire). Firstly mean weight and BMI were compared pre 
and post intervention using a paired t test. 
 
 
Table 8.3a Mean weight and BMI at baseline and 12 weeks  
 
Paired 
sample 
 
Mean pre 
intervention 
Mean post 
intervention 
Paired 
differences 
Std. Error 
Mean 
95% 
Confidence 
Interval of the 
difference 
Lower/Upper 
Sig. (2-
tailed) 
Weight 101.205 98.989 .6758 .7902/3.6420 .004 
BMI 38.406 37.844 .2561 .0209/1.103 .043 
 
 Table 8.3a indicates an overall mean weight loss and reduction in BMI over the pilot 
evaluation period for men and women. The difference in mean weight and BMI also reached 
statistical significance P<0.05. 
Positive and Negative Marker Foods 
 
Table 8.3b: Mean positive and negative marker foods score for men and women pre and post 
intervention 
Paired Sample Mean pre 
intervention 
Mean post 
intervention 
Paired 
differences 
Std. Error 
Mean 
Paired 
Differences 
95% 
Confidence 
interval of the 
difference 
Sig. (2-tailed) 
Positive marker 
foods 
6.2222 6.4444 .47524 -1.22489/ 
.78045 
.646 
Negative Marker 
Foods 
4.0000 3.2778 .61467 -.57461/ 
2.01905 
.256 
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Table 8.3b above indicates mean positive marker foods increased by 0.2 and negative marker 
foods decreased by almost one marker post intervention, no gender differences were 
associated with a decrease in negative marker foods however large confidence intervals 
suggest the sample size is too small, the results did not reach any statistical significance.  
8.4 Intake of selected foods during the pilot evaluation  
The following reports the proportion (%) of patients who claimed to have eaten a food item 
24 hours before the questionnaire was administered. The answers were compared pre 
intervention and post intervention 
   A higher percentage of patients reported eating a high fibre breakfast cereal post 
intervention.  
 Interestingly other vegetable intake increased by more than 50% post intervention 
 Fish cooked in other ways (boiled, grilled) increased by nearly 10% 
 Full fat cheese intake decreased by  more than 20% 
 Lean meat intake increased by 30% 
Though the findings did not reach any statistical significance (cross tabs indicated there was 
less males than females during the pilot study period to investigate differences pre and post 
intervention) 
8.5 Rosenburg Questionnaire   
The following data refers to the Rosenburg questionnaire during the pilot evaluation.  An 
overall score was calculated from ten questions. The scale ranges from 0-30. Scores between 
15 and 25 are within normal range; scores below 15 suggest low self-esteem.  Mean scores 
were calculated both pre and post pilot, however only ten patients completed the Rosenburg 
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correctly due to another form of the questionnaire being circulated. This problem was 
rectified before the evaluation commenced.  
 
8.6 Euroqol pilot results  
Table 8.6a: The following questions obtained from EQ5D were included in the evaluation to measure quality of life  
 
Question  Pre intervention 
(reported yes to the 
following) 
Percentage of sample  Post Intervention 
(reported yes to the 
following) 
Percentage of sample 
Mobility 
No problems 
Some Problems 
Extreme Problems 
 
6 
12 
 
33.3 
66.7 
 
5 
11 
1 
 
 
27.8 
61.1 
5.6 
Self Care 
No Problems 
Some Problems 
Extreme Problems 
 
13 
3 
2 
 
72.2 
16.7 
11.1 
 
10 
3 
1 
 
55.6 
16.7 
5.6 
Activity 
No Problems 
Some Problems 
Extreme Problems 
 
9 
6 
1 
 
25.7 
17.1 
2.9 
 
6 
8 
 
33.3 
44.4 
Pain  
No Problems 
Some Problems 
Extreme Problems 
 
9 
6 
2 
 
17.1 
25.7 
5.7 
 
4 
11 
2 
 
22.2 
61.1 
11.1 
Anxious 
No Problems 
Some Problems 
 
 
8 
8 
 
44.4 
44.4 
 
9 
7 
 
50 
38.9 
Health status 
Number 
Mean =67.5  72.5  
 
Table 5 shows a declining response percentage for patients who claimed to experience 
„Extreme problems‟ post intervention. Though the EQ5D results do not show any statistical 
Table 8.5a Pilot Rosenburg self esteem score pre and post intervention 
Paired Sample Mean pre 
intervention 
Mean post 
intervention 
Paired 
differences 
Std. Error 
Mean 
Paired 
Differences 
95% Confidence 
interval of the 
difference  
Sig. (2-tailed) 
Rosenburg Score 22.75 22 1.27825 
-2.27259/ 
3.77259 
.576 
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significance P<0.05 a larger sample size may indicate increased health status on completion 
of the weight management evaluation. 
 
9:  Three month evaluation SPSS tables (for questionnaires only) 
 
Food Intake results  
  
 
 
 
 
 
 
 
 
Table 9.2 Reported meal pattern for male and female patients 
 Start of 
Programme 
 P=value End of 
programme 
 P=value 1
ST
 week of 
programme 
compared 
with 12
th
 
week 
 
Value 
P=value 
Meal Male 
(n=19 ) 
n (%) 
Female 
(n=) 
n (%) 
 Male (n= 11) 
n (%) 
Female 
(n=21) 
n (%) 
 Df=1  
Eat at 
Breakfast  
15 (78.9) 24 
(77.4) 
NS 7  (63.6) 21 (100) P=0.003 4.097 P=0.043 
Eat at 
Lunchtime 
14 (73.7) 24 
(77.4) 
NS 9 (81.8) 18 (85.7) NS .395 NS 
Eat at 
Dinner 
Time 
18 (94.7) 27 
(87.1) 
NS 9 (81.8) 21 (100) P=0.044 .069 NS 
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Chart: 9.3 Reported positive marker food intake for female patients 
 
 
Chart: 9.4 Reported positive marker food intake for male patients  
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Chart 9.5 Reported negative marker food intake for female patients  
 
Chart 9.6 Reported negative marker food intake for male patients  
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Table 9.7: Mean intake of marker foods by duration of programme (paired t test data) 
 
Marker  
1
st
 week of programme  12  week of programme   P value  
 n= n= 95% CI  
 Mean  SD Mean  SD    
Positive 
marker 
foods 
(n=20) 
5.36 3.21711 4.96 4.48057 -.88906 1.68152 P=.539 
Negative 
marker 
foods 
(n=23) 
3.51 2.65752 2.02 2.64931 .60625 2.37488 P=0.001 
 
 
Table 9.8: SPSS data for ‘Rosenburg’ self esteem statements 
Question Answer Program 
Start 
 
 
Median  
answer 
Mean +SD Programme  
Finish 
 
 
Median 
Mean +SD 
Satisfied 
with myself 
 
Strongly Agree  
Agree  
Disagree  
Strongly disagree 
8 (25) 
8 (25) 
13 (40.6) 
3 (9.4) 
 
1.5 1.66 ± .97085 5 (17.2) 
17 (58.6) 
6 (20.7) 
1 (3.4) 
2 1.90 
±.72431 
At times no 
good 
Strongly Agree  
Agree  
Disagree  
Strongly disagree 
1 (3.2) 
12 (38.7) 
14 (45.2) 
4 (12.9) 
2 1.68 ±.74776 2 (7.1) 
3 (10.7) 
14 (50) 
8 (28.6) 
2 2.11±.9164
9 
Good 
qualities 
Strongly Agree  
Agree  
Disagree  
Strongly disagree 
 
7 (21.9) 
21 (65.6) 
2 (6.3) 
2 (6.3) 
2 2.03 ± .73985 9 (31) 
18 (62.1) 
2 (6.9) 
0 
2 2.24 
±.57664 
Do things 
well 
Strongly Agree  
Agree  
Disagree  
Strongly disagree 
7 (21.9) 
15 (46.9) 
8 (25) 
2 (6.3) 
2 1.85 ±.84660 5(17.2) 
18 (62.1) 
6(20.7) 
0 
2 1.97±.6258
0 
Not much 
to be proud 
off 
Strongly Agree  
Agree  
Disagree  
Strongly disagree 
1 (3.3) 
7 (23.3) 
15 (50) 
7 (23.3) 
2 1.93 ± .78492 0 
3 (10.3) 
14 (48.3) 
12 (41.4) 
 
2 2.31±.6602
7 
Feel useless 
at  times 
Strongly Agree  
Agree  
Disagree  
Strongly disagree 
1 (3.2) 
11 (35.5) 
15 (48.4) 
4 (12.9) 
2 1.71±.73908 2 (7.1) 
5 (17.9) 
16 (57.1) 
5 (18) 
2 1.89±.8751
4 
Person of 
worth  
Strongly Agree  
Agree  
Disagree  
Strongly disagree 
9 (30) 
16 (53.3) 
3 (10) 
2 (6.7) 
2 2.07 ±.82768 8 (27.6) 
16 (55.2) 
5 (17.2) 
0 
2 2.10±.6732
0 
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Table 9.8a: SPSS data for ‘Rosenburg’ score pre and post evaluation 
 
Paired Sample Start of Programme 
n= 21 
End of Programme 
n=21 
95% CI of the difference P 
 Mean  SD Mean  SD Difference                 
Rosenburg 
Score 
19.5714 4.66446 19.7619 3.64561 -1.83561 1.45465 .812 
 
I wish I 
could have 
more 
respect for 
myself 
Strongly Agree  
Agree  
Disagree  
Strongly disagree 
2 (6.3) 
16 (50) 
7 (21.9) 
7 (21.9) 
1 1.59 ±.91084 1(3.6) 
5 (17.9) 
12 (42.9) 
10 (35.7) 
2 2.14±.8908
7 
Feel that I 
am a 
failure 
Strongly Agree  
Agree  
Disagree  
Strongly disagree 
2 (6.5) 
5 (16.1) 
16 (51.6) 
8 (25.8) 
2 1.97±.83602 0  
3 (10.3) 
12 (41.4) 
14 (48.3) 
 
2 2.45±.7831
4 
Take a 
positive 
attitude  
Strongly Agree  
Agree  
Disagree  
Strongly disagree 
7 (21.9) 
18 (56.3) 
7 (21.9) 
0 
2 2 ± .67202 0 
7 (24.1) 
16 (55.2) 
6 (20.7) 
2 
 
 
2 
1.97±.6804
8 
Table 9.9: SPSS ‘Euroqol’ dimension results 
 
Question Programme 
Start  
Median 
Answer 
Mean +SD Programme 
Finish  
Median 
answer 
Mean + SD 
 n= 44   n= 33   
Mobility 
No problems 
 
Some Problems 
 
Extreme Problems 
 
17 (38.6) 
 
27 (61.4) 
 
0 
 
2 
 
1.6  ± .49254 
 
13 (39.4) 
 
18 (54.5) 
 
1 (3) 
 
2 
 
1.85 ± 
1.39466 
Self Care 
No Problems 
 
Some Problems 
 
Extreme Problems 
 
34 (77.3) 
 
7 (15.9) 
 
1 (2.3) 
 
1 
 
1.57 ± 1.70359 
 
24 (72.7) 
 
4 (12.1) 
 
1 (3) 
 
1 
 
 
2.15 ± 
2.62347 
Activity 
No Problems 
 
Some Problems 
 
23 (52.3) 
 
18 (40.9) 
1 1.81 ± 1.67433  
13 (39.4) 
 
16 (48.5) 
2 2.45 ± 
2.51360 
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Extreme Problems 
 
1 (2.3) 
 
0 
Pain  
No Problems 
 
Some Problems 
 
Extreme Problems 
 
11 (25) 
 
26 (59.1) 
 
6 (13.6) 
2 2.05 ± 1.23805  
10 (30.3) 
 
19 (57.6) 
 
3 (9.1) 
2 2.0 ± 1.39194 
Anxious 
No Problems 
 
Some Problems 
 
Extreme problems 
 
 
18 (40.9) 
 
23 (52.3) 
 
1 (2.3) 
2 1.93 ± 1.6408  
18 (54.5) 
 
13 (39.4) 
 
3 (9.1) 
1 1.88 ± 
1.89996 
Table 9.9a: SPSS ‘Euroqol’ health status results pre and post evaluation 
 
 1
st
 week of programme 12
th
 week of Programme 95% CI of the difference  P value 
 n=29 n=29 
 Mean  SD Mean  SD Lower   Upper 
Health 
Status 
Number  
44.8379 34.26125 70.3793 15.86419 -36.96965 -14.11311 P<0.001 
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THE END 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
